data_2k76_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k76 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.433 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 5.0 Cg_exo . . . . . 0 N--CA 1.486 1.061 0 N-CA-C 113.736 0.629 . . . . 0.0 113.736 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 3' ' ' PRO . 3.1 Cg_exo -69.92 132.98 24.19 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.174 1.916 . . . . 0.0 112.444 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.7 m -110.25 125.22 31.44 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.473 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 3.0 Cg_exo -54.07 150.79 30.16 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.411 1.407 . . . . 0.0 112.024 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.61 163.76 21.27 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.448 2.099 . . . . 0.0 112.241 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.69 172.72 52.2 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -64.55 -36.39 84.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.038 -1.272 . . . . 0.0 109.57 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.92 -28.9 68.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.406 -0.809 . . . . 0.0 110.153 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.39 141.14 71.59 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.174 -0.954 . . . . 0.0 110.002 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -54.35 149.44 37.61 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.541 2.161 . . . . 0.0 112.258 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.9 p -60.71 -22.49 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.327 -0.858 . . . . 0.0 109.743 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.87 -34.39 77.28 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -61.42 -38.08 85.81 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.474 ' CD1' ' O ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -61.9 -42.23 98.84 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.329 -0.857 . . . . 0.0 108.795 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.3 mt -60.3 -46.52 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.124 -0.985 . . . . 0.0 108.812 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.465 ' HG2' ' NH1' ' A' ' 18' ' ' ARG . 8.5 tpp85 -61.52 -40.18 93.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -0.858 . . . . 0.0 109.444 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.473 ' CD1' ' HA ' ' A' ' 6' ' ' PRO . 62.8 t80 -57.18 -45.71 83.44 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.214 -0.928 . . . . 0.0 108.499 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -59.72 -40.08 86.82 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -61.11 -47.3 86.93 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.586 0.708 . . . . 0.0 109.203 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -66.73 -39.75 88.1 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.249 -0.907 . . . . 0.0 109.346 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 32.8 tp -60.2 -40.03 88.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.243 -0.911 . . . . 0.0 108.892 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -59.06 -39.98 83.72 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.602 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 99.5 mm-40 -60.93 -38.74 86.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.395 -0.816 . . . . 0.0 108.918 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.435 ' O ' ' N ' ' A' ' 30' ' ' VAL . 76.4 t80 -55.45 -49.6 72.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.396 -0.815 . . . . 0.0 110.089 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.427 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 64.9 mt -60.62 -48.9 79.74 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.313 -0.867 . . . . 0.0 109.934 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.689 HD21 ' N ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -67.4 -37.02 82.46 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.888 -1.133 . . . . 0.0 108.155 178.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.602 ' CG2' ' O ' ' A' ' 25' ' ' GLN . 71.4 t -67.97 -39.04 80.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 121.426 0.631 . . . . 0.0 109.445 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.435 ' N ' ' O ' ' A' ' 26' ' ' TYR . 72.7 t . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.005 -0.997 . . . . 0.0 109.518 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.538 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 3.7 Cg_exo . . . . . 0 N--CA 1.49 1.267 0 N-CA-C 113.82 0.662 . . . . 0.0 113.82 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 3' ' ' PRO . 3.2 Cg_exo -64.21 139.21 65.11 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.228 1.952 . . . . 0.0 112.845 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.4 m -123.69 129.33 24.87 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.373 -0.829 . . . . 0.0 108.777 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -55.5 151.83 36.1 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 121.797 1.665 . . . . 0.0 112.471 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -76.51 166.14 27.87 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.333 2.022 . . . . 0.0 111.969 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.57 174.64 50.38 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -65.32 -36.58 84.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.102 -1.234 . . . . 0.0 109.843 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -66.56 -31.47 72.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.333 -0.854 . . . . 0.0 110.03 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.81 139.64 77.0 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.056 -1.027 . . . . 0.0 109.549 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -53.74 152.57 21.89 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.254 1.97 . . . . 0.0 111.884 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.0 m -64.36 -29.34 47.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.242 -0.911 . . . . 0.0 109.247 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -60.61 -36.04 77.63 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -59.58 -39.67 84.89 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.8 tt -60.54 -40.46 91.63 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.404 -0.81 . . . . 0.0 109.007 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.2 mt -58.34 -48.32 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.199 -0.938 . . . . 0.0 109.502 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.642 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 54.0 mtp180 -60.05 -38.01 81.53 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.15 -0.969 . . . . 0.0 109.19 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -54.88 -42.23 71.83 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -60.22 -38.67 84.08 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.642 ' ND2' ' O ' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -58.63 -47.85 83.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.371 -0.831 . . . . 0.0 109.647 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.591 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 93.0 m-20 -59.66 -38.53 81.71 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.117 -0.989 . . . . 0.0 108.887 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.6 tp -59.34 -38.42 80.33 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -59.16 -44.27 92.11 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.365 -0.834 . . . . 0.0 108.942 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -65.11 -37.0 86.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.385 -0.822 . . . . 0.0 109.398 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -57.21 -47.22 81.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.563 -0.71 . . . . 0.0 110.641 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 76.3 mt -69.24 -39.85 78.26 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.198 -0.938 . . . . 0.0 110.114 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.723 HD21 ' N ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -63.99 -42.38 97.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.139 -0.976 . . . . 0.0 110.244 -179.529 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.418 ' O ' ' OXT' ' A' ' 30' ' ' VAL . 21.6 m -79.31 -30.56 14.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 121.177 -0.952 . . . . 0.0 109.932 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.418 ' OXT' ' O ' ' A' ' 29' ' ' VAL . 41.1 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.424 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo . . . . . 0 N--CA 1.483 0.874 0 CA-C-O 120.986 0.328 . . . . 0.0 112.09 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -52.75 147.13 32.66 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.614 2.21 . . . . 0.0 112.129 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.402 ' H ' HG22 ' A' ' 5' ' ' THR . 3.0 t -125.41 79.59 66.63 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 108.985 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.493 ' HG3' ' CD1' ' A' ' 19' ' ' PHE . 2.7 Cg_endo -55.96 156.39 19.93 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.126 1.884 . . . . 0.0 111.98 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -69.31 -62.99 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 121.784 1.656 . . . . 0.0 111.79 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 167.91 173.29 35.8 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -62.67 -31.35 72.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -1.185 . . . . 0.0 109.974 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -60.21 -31.02 69.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.353 -0.842 . . . . 0.0 109.635 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.461 ' CB ' ' OD2' ' A' ' 15' ' ' ASP . . . -66.89 147.57 99.04 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.102 -0.999 . . . . 0.0 109.489 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -49.65 147.87 12.75 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.532 2.155 . . . . 0.0 112.079 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.02 -18.83 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.317 -0.864 . . . . 0.0 109.568 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.18 -34.84 75.7 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.461 ' OD2' ' CB ' ' A' ' 11' ' ' ALA . 90.1 m-20 -62.22 -39.34 92.45 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.1 tp -58.38 -41.12 84.12 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.8 mt -55.79 -49.97 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.365 -0.834 . . . . 0.0 109.486 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.711 ' HE ' ' C ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -54.36 -42.52 70.39 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.772 -1.205 . . . . 0.0 108.231 -179.542 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.518 ' N ' ' HE ' ' A' ' 18' ' ' ARG . 67.7 t80 -60.67 -37.47 81.68 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.399 -0.813 . . . . 0.0 108.924 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.765 ' CD1' ' N ' ' A' ' 21' ' ' ASN . 0.0 OUTLIER -56.27 -53.88 51.94 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.551 -0.718 . . . . 0.0 109.429 -179.448 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.765 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 1.7 p30 -66.12 -37.64 86.22 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.424 -0.798 . . . . 0.0 110.154 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.587 ' OD2' ' NE ' ' A' ' 18' ' ' ARG . 89.5 m-20 -62.48 -43.93 97.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.945 -1.097 . . . . 0.0 109.716 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.9 tp -66.12 -38.68 88.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 109.562 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -58.8 -46.05 88.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 109.472 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -64.25 -37.79 88.72 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.193 -0.942 . . . . 0.0 109.206 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -55.8 -44.32 77.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.522 -0.737 . . . . 0.0 110.261 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 38.9 mt -68.45 -40.9 80.92 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.418 -0.801 . . . . 0.0 110.129 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.653 HD21 ' N ' ' A' ' 28' ' ' ASN . 0.8 OUTLIER -63.7 -39.8 95.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.245 -0.91 . . . . 0.0 110.289 -179.598 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.554 ' O ' ' O ' ' A' ' 30' ' ' VAL . 32.8 m -77.03 -30.8 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 120.998 -1.063 . . . . 0.0 109.402 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.554 ' O ' ' O ' ' A' ' 29' ' ' VAL . 69.0 t . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.554 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.536 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 3.2 Cg_exo . . . . . 0 CA--C 1.549 1.237 0 N-CA-C 115.057 1.137 . . . . 0.0 115.057 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 3' ' ' PRO . 3.2 Cg_exo -53.38 133.54 53.49 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.302 1.334 . . . . 0.0 112.883 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.3 t -126.34 86.19 58.65 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.43 ' HG3' ' CD1' ' A' ' 19' ' ' PHE . 3.0 Cg_endo -55.98 151.6 40.93 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 121.78 1.653 . . . . 0.0 112.201 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -65.68 -62.36 0.08 OUTLIER 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 121.917 1.745 . . . . 0.0 111.884 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.45 175.57 44.8 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -66.5 -34.93 79.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -1.097 . . . . 0.0 109.794 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.8 mp0 -63.65 -26.91 68.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.37 -0.831 . . . . 0.0 110.35 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.95 146.5 67.91 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.06 -1.025 . . . . 0.0 109.966 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -50.49 150.6 11.38 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.652 2.235 . . . . 0.0 112.079 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.7 p -58.83 -21.16 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 0.0 110.21 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.95 -37.06 86.02 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.0 -1.063 . . . . 0.0 108.637 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -64.26 -39.81 94.71 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.1 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.2 tp -63.28 -39.98 96.09 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.348 -0.845 . . . . 0.0 109.513 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 84.2 mt -57.88 -48.89 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.22 -0.925 . . . . 0.0 109.482 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.586 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 1.3 ttm105 -55.63 -38.96 70.19 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.207 -0.933 . . . . 0.0 109.007 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.43 ' CD1' ' HG3' ' A' ' 6' ' ' PRO . 86.8 t80 -59.44 -45.46 91.51 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.176 -0.952 . . . . 0.0 109.109 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -62.69 -41.34 99.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.408 -0.808 . . . . 0.0 110.077 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.789 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 26.0 p30 -63.9 -33.84 76.6 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.109 -0.994 . . . . 0.0 109.997 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.789 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 78.2 m-20 -67.39 -42.72 82.87 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.909 -1.119 . . . . 0.0 108.494 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.6 tp -62.69 -38.22 89.57 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -58.35 -40.29 81.79 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -62.56 -38.36 89.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.317 -0.864 . . . . 0.0 108.976 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -55.45 -51.25 67.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.471 -0.768 . . . . 0.0 109.604 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 79.3 mt -67.27 -36.21 81.11 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.544 -0.723 . . . . 0.0 109.369 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -61.09 -44.13 97.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.499 -0.751 . . . . 0.0 110.472 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.579 ' O ' ' OXT' ' A' ' 30' ' ' VAL . 35.5 m -76.35 -30.58 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.078 -1.014 . . . . 0.0 109.887 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.579 ' OXT' ' O ' ' A' ' 29' ' ' VAL . 43.6 t . . . . . 0 C--N 1.302 -1.489 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.584 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.531 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 3.8 Cg_exo . . . . . 0 N--CA 1.488 1.186 0 N-CA-C 114.181 0.801 . . . . 0.0 114.181 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 3' ' ' PRO . 3.0 Cg_exo -62.62 144.42 94.22 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.034 1.823 . . . . 0.0 112.559 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.62 125.57 36.94 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.317 -0.865 . . . . 0.0 108.913 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -56.51 151.05 48.06 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.809 1.672 . . . . 0.0 112.494 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -69.05 174.62 8.63 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.144 1.896 . . . . 0.0 111.86 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.21 172.88 54.84 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 55.6 mp0 -67.09 -44.96 78.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.992 -1.299 . . . . 0.0 110.012 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -83.71 -2.97 57.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.208 -0.933 . . . . 0.0 109.549 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.34 143.16 93.19 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 109.776 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -52.36 149.26 23.44 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.569 2.179 . . . . 0.0 112.276 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 m -65.55 -23.5 32.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.437 -0.79 . . . . 0.0 109.265 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -61.71 -36.3 80.54 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -61.05 -39.84 91.36 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.704 -0.798 . . . . 0.0 109.024 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.7 tt -61.15 -39.85 91.62 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.0 mt -63.25 -42.83 97.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -57.57 -38.55 74.99 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.465 ' CE2' ' HB2' ' A' ' 4' ' ' PRO . 37.6 t80 -58.78 -41.57 86.96 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.37 -0.831 . . . . 0.0 108.795 178.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -58.77 -44.41 90.62 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.447 -0.783 . . . . 0.0 109.759 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.791 ' ND2' ' N ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -64.41 -38.55 91.42 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.044 -1.035 . . . . 0.0 109.397 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.791 ' N ' ' ND2' ' A' ' 21' ' ' ASN . 48.6 t0 -64.33 -29.78 70.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.139 -0.976 . . . . 0.0 109.117 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.7 tt -68.83 -38.71 80.01 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.081 -1.012 . . . . 0.0 108.593 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -59.14 -45.94 89.65 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.468 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 44.9 tt0 -63.55 -34.18 77.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.944 . . . . 0.0 108.749 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.606 ' CD1' ' C ' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -64.4 -54.17 36.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.581 -0.699 . . . . 0.0 110.494 -179.572 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.8 mt -78.29 -37.01 45.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -0.992 . . . . 0.0 110.577 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -60.51 -42.31 96.13 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.149 -0.97 . . . . 0.0 111.03 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.468 ' CG2' ' O ' ' A' ' 25' ' ' GLN . 35.2 m -71.08 -29.93 38.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 C--N 1.303 -1.434 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.837 179.099 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.535 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 3.7 Cg_exo . . . . . 0 N--CA 1.489 1.211 0 N-CA-C 113.915 0.698 . . . . 0.0 113.915 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 3' ' ' PRO . 3.5 Cg_exo -63.04 127.84 21.37 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 121.908 1.739 . . . . 0.0 112.109 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.575 ' O ' ' CE2' ' A' ' 19' ' ' PHE . 30.0 m -118.12 109.58 40.7 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -56.16 149.76 52.29 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.333 1.355 . . . . 0.0 112.908 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.428 ' CG ' ' OD1' ' A' ' 15' ' ' ASP . 2.4 Cg_endo -65.51 164.91 24.43 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.624 2.216 . . . . 0.0 112.008 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.3 174.16 55.24 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -66.27 -37.59 85.83 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.015 -1.285 . . . . 0.0 110.173 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.79 -31.83 71.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.299 -0.876 . . . . 0.0 110.42 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.34 147.91 94.27 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.917 . . . . 0.0 110.255 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.614 ' O ' ' OD1' ' A' ' 15' ' ' ASP . 2.9 Cg_endo -50.55 144.95 23.66 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.855 2.37 . . . . 0.0 112.271 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.7 p -65.8 -20.62 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.442 -0.786 . . . . 0.0 110.451 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 57.8 mp0 -63.23 -39.26 94.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.886 -1.134 . . . . 0.0 109.439 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.733 ' OD1' ' N ' ' A' ' 16' ' ' LEU . 46.8 p30 -63.72 -36.72 84.8 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.127 -0.983 . . . . 0.0 109.202 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.733 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 1.1 tp -64.48 -39.16 93.27 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.279 -0.888 . . . . 0.0 109.251 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.0 mt -57.43 -50.81 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.452 -0.78 . . . . 0.0 110.023 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.588 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 0.2 OUTLIER -60.63 -41.4 94.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.018 -1.051 . . . . 0.0 110.128 -179.568 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.575 ' CE2' ' O ' ' A' ' 5' ' ' THR . 7.0 m-85 -67.79 -36.51 80.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.87 -1.144 . . . . 0.0 109.189 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -57.01 -39.46 74.78 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.809 ' ND2' ' N ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -66.7 -43.13 85.2 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.109 179.454 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.809 ' N ' ' ND2' ' A' ' 21' ' ' ASN . 93.9 m-20 -60.34 -37.26 80.07 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.447 HD23 ' N ' ' A' ' 23' ' ' LEU . 4.0 mm? -64.74 -36.38 84.1 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -53.67 -42.22 67.67 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.664 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 97.5 mt-30 -67.79 -38.32 83.2 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.41 ' HB3' ' O ' ' A' ' 23' ' ' LEU . 88.7 t80 -55.85 -48.24 75.85 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.609 -0.682 . . . . 0.0 109.983 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 36.4 mt -62.76 -49.98 72.85 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.483 -0.76 . . . . 0.0 110.283 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -69.13 -36.2 77.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.831 -1.168 . . . . 0.0 108.359 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.664 ' CG2' ' O ' ' A' ' 25' ' ' GLN . 62.4 t -65.78 -37.8 80.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.492 ' O ' ' O ' ' A' ' 29' ' ' VAL . 74.0 t . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.359 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo . . . . . 0 N--CA 1.489 1.231 0 CA-C-O 120.667 0.195 . . . . 0.0 112.216 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -59.7 150.28 77.77 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.139 1.893 . . . . 0.0 111.625 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 m -123.46 79.28 54.35 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.134 -0.979 . . . . 0.0 109.352 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.486 ' HG3' ' CE1' ' A' ' 19' ' ' PHE . 2.4 Cg_endo -57.44 152.39 47.4 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.028 1.818 . . . . 0.0 112.362 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -73.28 -147.41 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.184 0 C-N-CA 121.816 1.677 . . . . 0.0 111.378 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -83.93 175.23 51.67 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -66.84 -37.67 84.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.111 -1.229 . . . . 0.0 110.089 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.486 ' O ' ' C ' ' A' ' 11' ' ' ALA . 96.9 mt-10 -67.6 -26.98 66.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.319 -0.863 . . . . 0.0 110.519 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.486 ' C ' ' O ' ' A' ' 10' ' ' GLU . . . -36.88 150.61 0.13 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.069 -1.019 . . . . 0.0 110.075 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -50.26 149.15 12.88 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.926 2.417 . . . . 0.0 111.934 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 m -65.47 -19.64 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.157 -0.964 . . . . 0.0 109.459 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.16 -38.14 89.99 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -65.83 -38.77 89.81 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.159 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.3 tp -60.99 -42.73 98.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.319 -0.863 . . . . 0.0 109.329 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 72.5 mt -59.8 -49.23 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.41 -0.806 . . . . 0.0 109.433 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.699 ' HE ' ' N ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -55.68 -35.45 66.03 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.442 -0.786 . . . . 0.0 109.036 179.695 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.699 ' N ' ' HE ' ' A' ' 18' ' ' ARG . 93.9 t80 -61.67 -52.03 66.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.214 -0.928 . . . . 0.0 108.935 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -58.74 -39.44 80.9 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -60.86 -45.12 95.81 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -69.44 -39.32 77.89 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.565 -0.71 . . . . 0.0 109.715 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.2 tp -58.37 -43.18 88.32 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.242 -0.912 . . . . 0.0 108.934 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.455 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 53.5 tt0 -61.09 -39.72 91.0 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.463 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 47.4 tt0 -59.85 -40.0 87.08 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.502 -0.749 . . . . 0.0 109.202 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -66.47 -51.22 59.14 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.341 -0.849 . . . . 0.0 110.434 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.404 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 60.8 mt -74.85 -38.97 61.84 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 110.245 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 24' ' ' GLN . 27.9 t30 -60.28 -43.06 96.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.334 -0.854 . . . . 0.0 110.885 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.463 ' CG2' ' O ' ' A' ' 25' ' ' GLN . 25.2 m -72.41 -30.58 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 120.913 -1.117 . . . . 0.0 108.727 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 27' ' ' LEU . 78.1 t . . . . . 0 C--N 1.304 -1.411 0 CA-C-O 118.066 -0.968 . . . . 0.0 109.812 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.509 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 3.5 Cg_exo . . . . . 0 N--CA 1.491 1.329 0 N-CA-C 114.118 0.776 . . . . 0.0 114.118 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.509 ' CD ' ' N ' ' A' ' 3' ' ' PRO . 3.9 Cg_exo -62.65 130.98 31.53 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.967 1.778 . . . . 0.0 112.458 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 t -126.27 86.88 57.27 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 109.072 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.474 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 3.0 Cg_exo -55.67 151.58 38.55 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.585 1.523 . . . . 0.0 112.138 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.551 ' CD ' ' OD1' ' A' ' 15' ' ' ASP . 2.8 Cg_endo -58.89 -69.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.589 2.192 . . . . 0.0 111.984 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.89 175.7 40.94 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.14 -33.64 75.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.382 -1.069 . . . . 0.0 110.082 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -58.66 -32.62 69.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -0.931 . . . . 0.0 109.736 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.88 149.49 92.63 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.245 -0.909 . . . . 0.0 109.851 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -50.0 146.55 16.76 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.741 2.294 . . . . 0.0 111.99 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.11 -18.3 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.325 -0.859 . . . . 0.0 110.205 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.79 -36.21 82.39 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 120.974 -1.078 . . . . 0.0 109.16 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.551 ' OD1' ' CD ' ' A' ' 7' ' ' PRO . 13.3 t70 -61.94 -41.54 98.09 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.573 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 45.0 mt -65.58 -36.63 84.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.001 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.444 HD11 HG22 ' A' ' 17' ' ' ILE . 71.7 mt -59.43 -49.62 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.072 -1.018 . . . . 0.0 110.146 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.508 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 22.9 mtp180 -62.58 -42.03 99.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.651 -1.281 . . . . 0.0 109.471 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.474 ' CE2' ' HA ' ' A' ' 6' ' ' PRO . 6.9 m-85 -61.18 -34.64 75.38 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -58.01 -38.15 75.62 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -59.35 -45.96 89.96 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.028 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -61.79 -37.49 84.56 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 mt -62.73 -36.74 83.98 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.498 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 63.5 tt0 -58.93 -47.67 84.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.354 -0.842 . . . . 0.0 108.926 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.537 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 61.1 tt0 -63.7 -41.35 98.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.169 -0.957 . . . . 0.0 108.92 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.618 ' CD1' ' C ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -66.03 -51.68 56.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.609 -0.682 . . . . 0.0 110.071 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.457 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 89.4 mt -74.08 -38.47 63.89 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.918 -1.114 . . . . 0.0 110.325 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 24' ' ' GLN . 25.3 t30 -62.83 -42.58 99.79 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.991 -1.068 . . . . 0.0 110.56 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 25' ' ' GLN . 31.3 m -76.85 -31.09 18.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 120.92 -1.113 . . . . 0.0 108.778 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.502 ' O ' ' O ' ' A' ' 29' ' ' VAL . 76.9 t . . . . . 0 C--N 1.304 -1.394 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.696 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.523 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 4.1 Cg_exo . . . . . 0 N--CA 1.488 1.193 0 N-CA-C 114.079 0.761 . . . . 0.0 114.079 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' A' ' 3' ' ' PRO . 3.2 Cg_exo -64.41 140.75 71.3 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.324 2.016 . . . . 0.0 112.514 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.64 144.21 30.95 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.298 -0.876 . . . . 0.0 108.919 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -56.0 151.07 43.74 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.104 1.869 . . . . 0.0 111.986 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -79.03 168.02 21.17 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.199 1.933 . . . . 0.0 111.885 178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.37 155.89 53.18 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -60.88 -38.93 87.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.885 -1.362 . . . . 0.0 109.346 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -71.73 -24.75 61.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.466 -0.772 . . . . 0.0 109.993 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.76 142.42 16.43 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.131 -0.981 . . . . 0.0 110.022 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -52.71 148.34 28.43 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.605 2.204 . . . . 0.0 112.073 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.02 -23.17 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.296 -0.877 . . . . 0.0 109.734 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.67 -33.5 75.76 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 120.954 -1.092 . . . . 0.0 108.435 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -61.3 -40.34 93.8 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.468 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.523 HD12 ' H ' ' A' ' 16' ' ' LEU . 6.6 mp -62.19 -41.3 98.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.131 -0.981 . . . . 0.0 108.735 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.2 mt -58.97 -44.25 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.427 -0.909 . . . . 0.0 108.684 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.453 ' HG3' ' ND2' ' A' ' 21' ' ' ASN . 18.9 ttm180 -61.69 -38.62 88.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.391 -0.818 . . . . 0.0 109.446 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -55.74 -46.36 77.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.261 -0.899 . . . . 0.0 108.889 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -61.68 -39.19 90.55 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.569 ' ND2' ' OD1' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -60.0 -44.46 94.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.408 -0.808 . . . . 0.0 109.344 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.569 ' OD1' ' ND2' ' A' ' 21' ' ' ASN . 89.9 m-20 -59.51 -40.74 88.09 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.285 -0.885 . . . . 0.0 109.718 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 38.0 tp -60.07 -41.07 91.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.023 -1.048 . . . . 0.0 108.959 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.446 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 46.1 tt0 -60.81 -38.46 85.46 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.522 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 61.8 tp60 -60.58 -40.21 90.91 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.393 -0.817 . . . . 0.0 108.953 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.442 ' CD1' ' C ' ' A' ' 26' ' ' TYR . 25.2 t80 -69.02 -52.54 27.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.348 -0.845 . . . . 0.0 110.079 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.48 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 78.2 mt -70.16 -37.53 75.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.358 -0.839 . . . . 0.0 110.237 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 24' ' ' GLN . 29.1 t30 -68.29 -41.29 81.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.117 -0.989 . . . . 0.0 110.83 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 25' ' ' GLN . 17.3 m -78.99 -35.19 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 120.974 -1.079 . . . . 0.0 109.49 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.48 ' CG2' ' O ' ' A' ' 27' ' ' LEU . 25.1 t . . . . . 0 C--N 1.302 -1.472 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.607 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.505 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 3.5 Cg_exo . . . . . 0 N--CA 1.49 1.293 0 N-CA-C 114.018 0.738 . . . . 0.0 114.018 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.505 ' CD ' ' N ' ' A' ' 3' ' ' PRO . 3.5 Cg_exo -59.7 140.89 95.68 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.693 1.595 . . . . 0.0 112.367 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.34 160.98 39.39 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -55.55 150.9 40.79 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 121.628 1.552 . . . . 0.0 111.799 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -79.29 -67.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.921 1.747 . . . . 0.0 112.296 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 145.26 148.12 4.76 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -57.88 -44.55 86.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.036 -1.273 . . . . 0.0 109.979 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -71.9 -29.14 64.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.912 . . . . 0.0 109.558 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -46.93 124.83 8.26 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.278 -0.889 . . . . 0.0 109.992 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.86 155.89 52.02 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 121.971 1.781 . . . . 0.0 111.688 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.9 p -56.01 -19.26 6.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.223 -0.923 . . . . 0.0 109.881 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -64.89 -41.93 95.2 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.987 -1.07 . . . . 0.0 108.545 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -67.03 -40.97 87.34 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.719 -0.792 . . . . 0.0 109.095 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.4 -38.53 87.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.391 -0.818 . . . . 0.0 109.091 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 54.2 mt -57.65 -53.83 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.423 -0.798 . . . . 0.0 110.209 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.698 ' HE ' ' C ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -55.59 -39.55 70.87 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.097 -1.002 . . . . 0.0 108.52 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.56 ' N ' ' HE ' ' A' ' 18' ' ' ARG . 13.3 t80 -62.42 -42.96 99.84 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.443 -0.786 . . . . 0.0 109.191 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -58.4 -43.49 88.58 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.481 -0.762 . . . . 0.0 109.541 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.766 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 28.1 p30 -69.06 -32.87 72.65 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.142 -0.974 . . . . 0.0 109.967 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.766 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 88.0 m-20 -63.55 -44.35 94.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.156 -0.965 . . . . 0.0 109.618 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.7 tp -65.87 -40.21 91.41 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.319 -0.863 . . . . 0.0 109.493 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.445 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 36.0 tt0 -60.39 -47.61 85.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 109.21 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.534 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 97.3 mt-30 -66.01 -33.47 75.88 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.21 -0.931 . . . . 0.0 108.844 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.566 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.8 OUTLIER -64.37 -55.75 19.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.465 -0.772 . . . . 0.0 110.363 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.2 mt -76.93 -38.81 52.67 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.093 -1.004 . . . . 0.0 110.381 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.445 ' CB ' ' O ' ' A' ' 24' ' ' GLN . 17.9 t30 -61.72 -43.12 99.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.152 -0.968 . . . . 0.0 110.74 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.575 ' O ' ' O ' ' A' ' 30' ' ' VAL . 15.7 m -71.76 -30.8 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 120.921 -1.112 . . . . 0.0 108.82 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.575 ' O ' ' O ' ' A' ' 29' ' ' VAL . 71.4 t . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.586 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.48 0.734 0 N-CA-C 109.539 -0.985 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.747 ' CG ' ' O ' ' A' ' 2' ' ' PHE . 1.8 p90 -122.66 94.75 47.3 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.122 -0.986 . . . . 0.0 109.547 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.433 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 5.0 Cg_exo -61.01 -47.38 12.82 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.444 2.096 . . . . 0.0 113.736 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' A' ' 3' ' ' PRO . 3.1 Cg_exo -69.92 132.98 24.19 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.174 1.916 . . . . 0.0 112.444 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.7 m -110.25 125.22 31.44 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.473 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 3.0 Cg_exo -54.07 150.79 30.16 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.411 1.407 . . . . 0.0 112.024 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.61 163.76 21.27 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.448 2.099 . . . . 0.0 112.241 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.69 172.72 52.2 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -64.55 -36.39 84.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.038 -1.272 . . . . 0.0 109.57 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.92 -28.9 68.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.406 -0.809 . . . . 0.0 110.153 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.39 141.14 71.59 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.174 -0.954 . . . . 0.0 110.002 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -54.35 149.44 37.61 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.541 2.161 . . . . 0.0 112.258 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.9 p -60.71 -22.49 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.327 -0.858 . . . . 0.0 109.743 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.87 -34.39 77.28 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -61.42 -38.08 85.81 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.474 ' CD1' ' O ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -61.9 -42.23 98.84 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.329 -0.857 . . . . 0.0 108.795 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.3 mt -60.3 -46.52 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.124 -0.985 . . . . 0.0 108.812 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.465 ' HG2' ' NH1' ' A' ' 18' ' ' ARG . 8.5 tpp85 -61.52 -40.18 93.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -0.858 . . . . 0.0 109.444 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.473 ' CD1' ' HA ' ' A' ' 6' ' ' PRO . 62.8 t80 -57.18 -45.71 83.44 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.214 -0.928 . . . . 0.0 108.499 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -59.72 -40.08 86.82 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -61.11 -47.3 86.93 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.586 0.708 . . . . 0.0 109.203 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -66.73 -39.75 88.1 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.249 -0.907 . . . . 0.0 109.346 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 32.8 tp -60.2 -40.03 88.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.243 -0.911 . . . . 0.0 108.892 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -59.06 -39.98 83.72 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.602 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 99.5 mm-40 -60.93 -38.74 86.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.395 -0.816 . . . . 0.0 108.918 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.435 ' O ' ' N ' ' A' ' 30' ' ' VAL . 76.4 t80 -55.45 -49.6 72.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.396 -0.815 . . . . 0.0 110.089 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.427 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 64.9 mt -60.62 -48.9 79.74 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.313 -0.867 . . . . 0.0 109.934 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.689 HD21 ' N ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -67.4 -37.02 82.46 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.888 -1.133 . . . . 0.0 108.155 178.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.602 ' CG2' ' O ' ' A' ' 25' ' ' GLN . 71.4 t -67.97 -39.04 80.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 121.426 0.631 . . . . 0.0 109.445 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.435 ' N ' ' O ' ' A' ' 26' ' ' TYR . 72.7 t . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.005 -0.997 . . . . 0.0 109.518 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.481 0.749 0 N-CA-C 109.739 -0.908 . . . . 0.0 109.739 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.671 ' CG ' ' O ' ' A' ' 2' ' ' PHE . 2.5 p90 -58.76 112.21 4.7 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.188 -0.945 . . . . 0.0 109.547 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.538 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 3.7 Cg_exo -60.58 -42.36 40.61 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.497 2.131 . . . . 0.0 113.82 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.619 ' O ' ' CE2' ' A' ' 2' ' ' PHE . 3.2 Cg_exo -64.21 139.21 65.11 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.228 1.952 . . . . 0.0 112.845 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.4 m -123.69 129.33 24.87 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.373 -0.829 . . . . 0.0 108.777 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -55.5 151.83 36.1 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 121.797 1.665 . . . . 0.0 112.471 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -76.51 166.14 27.87 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.333 2.022 . . . . 0.0 111.969 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.57 174.64 50.38 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -65.32 -36.58 84.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.102 -1.234 . . . . 0.0 109.843 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -66.56 -31.47 72.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.333 -0.854 . . . . 0.0 110.03 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.81 139.64 77.0 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.056 -1.027 . . . . 0.0 109.549 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -53.74 152.57 21.89 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.254 1.97 . . . . 0.0 111.884 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.0 m -64.36 -29.34 47.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.242 -0.911 . . . . 0.0 109.247 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -60.61 -36.04 77.63 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -59.58 -39.67 84.89 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.8 tt -60.54 -40.46 91.63 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.404 -0.81 . . . . 0.0 109.007 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.2 mt -58.34 -48.32 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.199 -0.938 . . . . 0.0 109.502 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.642 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 54.0 mtp180 -60.05 -38.01 81.53 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.15 -0.969 . . . . 0.0 109.19 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -54.88 -42.23 71.83 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -60.22 -38.67 84.08 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.642 ' ND2' ' O ' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -58.63 -47.85 83.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.371 -0.831 . . . . 0.0 109.647 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.591 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 93.0 m-20 -59.66 -38.53 81.71 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.117 -0.989 . . . . 0.0 108.887 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.6 tp -59.34 -38.42 80.33 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -59.16 -44.27 92.11 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.365 -0.834 . . . . 0.0 108.942 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -65.11 -37.0 86.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.385 -0.822 . . . . 0.0 109.398 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -57.21 -47.22 81.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.563 -0.71 . . . . 0.0 110.641 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 76.3 mt -69.24 -39.85 78.26 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.198 -0.938 . . . . 0.0 110.114 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.723 HD21 ' N ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -63.99 -42.38 97.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.139 -0.976 . . . . 0.0 110.244 -179.529 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.418 ' O ' ' OXT' ' A' ' 30' ' ' VAL . 21.6 m -79.31 -30.56 14.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 121.177 -0.952 . . . . 0.0 109.932 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.418 ' OXT' ' O ' ' A' ' 29' ' ' VAL . 41.1 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.424 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo . . . . . 0 N--CA 1.481 0.789 0 N-CA-C 109.721 -0.915 . . . . 0.0 109.721 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -53.57 153.77 7.33 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.314 -0.866 . . . . 0.0 109.856 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -72.61 144.86 40.69 Favored 'Trans proline' 0 C--N 1.32 -0.953 0 C-N-CA 121.448 1.432 . . . . 0.0 112.09 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -52.75 147.13 32.66 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.614 2.21 . . . . 0.0 112.129 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.402 ' H ' HG22 ' A' ' 5' ' ' THR . 3.0 t -125.41 79.59 66.63 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 108.985 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.493 ' HG3' ' CD1' ' A' ' 19' ' ' PHE . 2.7 Cg_endo -55.96 156.39 19.93 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.126 1.884 . . . . 0.0 111.98 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -69.31 -62.99 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 121.784 1.656 . . . . 0.0 111.79 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 167.91 173.29 35.8 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -62.67 -31.35 72.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -1.185 . . . . 0.0 109.974 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -60.21 -31.02 69.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.353 -0.842 . . . . 0.0 109.635 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.461 ' CB ' ' OD2' ' A' ' 15' ' ' ASP . . . -66.89 147.57 99.04 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.102 -0.999 . . . . 0.0 109.489 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -49.65 147.87 12.75 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.532 2.155 . . . . 0.0 112.079 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.02 -18.83 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.317 -0.864 . . . . 0.0 109.568 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.18 -34.84 75.7 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.461 ' OD2' ' CB ' ' A' ' 11' ' ' ALA . 90.1 m-20 -62.22 -39.34 92.45 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.1 tp -58.38 -41.12 84.12 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.8 mt -55.79 -49.97 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.365 -0.834 . . . . 0.0 109.486 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.711 ' HE ' ' C ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -54.36 -42.52 70.39 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.772 -1.205 . . . . 0.0 108.231 -179.542 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.518 ' N ' ' HE ' ' A' ' 18' ' ' ARG . 67.7 t80 -60.67 -37.47 81.68 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.399 -0.813 . . . . 0.0 108.924 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.765 ' CD1' ' N ' ' A' ' 21' ' ' ASN . 0.0 OUTLIER -56.27 -53.88 51.94 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.551 -0.718 . . . . 0.0 109.429 -179.448 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.765 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 1.7 p30 -66.12 -37.64 86.22 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.424 -0.798 . . . . 0.0 110.154 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.587 ' OD2' ' NE ' ' A' ' 18' ' ' ARG . 89.5 m-20 -62.48 -43.93 97.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.945 -1.097 . . . . 0.0 109.716 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.9 tp -66.12 -38.68 88.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 109.562 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -58.8 -46.05 88.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 109.472 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -64.25 -37.79 88.72 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.193 -0.942 . . . . 0.0 109.206 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -55.8 -44.32 77.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.522 -0.737 . . . . 0.0 110.261 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 38.9 mt -68.45 -40.9 80.92 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.418 -0.801 . . . . 0.0 110.129 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.653 HD21 ' N ' ' A' ' 28' ' ' ASN . 0.8 OUTLIER -63.7 -39.8 95.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.245 -0.91 . . . . 0.0 110.289 -179.598 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.554 ' O ' ' O ' ' A' ' 30' ' ' VAL . 32.8 m -77.03 -30.8 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 120.998 -1.063 . . . . 0.0 109.402 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.554 ' O ' ' O ' ' A' ' 29' ' ' VAL . 69.0 t . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.554 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo . . . . . 0 N--CA 1.481 0.79 0 N-CA-C 109.862 -0.861 . . . . 0.0 109.862 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.691 ' CG ' ' O ' ' A' ' 2' ' ' PHE . 2.8 p90 -56.59 111.87 3.8 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 109.614 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.536 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 3.2 Cg_exo -64.59 -36.12 44.22 Favored 'Trans proline' 0 CA--C 1.549 1.237 0 C-N-CA 122.581 2.187 . . . . 0.0 115.057 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 3' ' ' PRO . 3.2 Cg_exo -53.38 133.54 53.49 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.302 1.334 . . . . 0.0 112.883 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.3 t -126.34 86.19 58.65 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.43 ' HG3' ' CD1' ' A' ' 19' ' ' PHE . 3.0 Cg_endo -55.98 151.6 40.93 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 121.78 1.653 . . . . 0.0 112.201 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -65.68 -62.36 0.08 OUTLIER 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 121.917 1.745 . . . . 0.0 111.884 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.45 175.57 44.8 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -66.5 -34.93 79.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -1.097 . . . . 0.0 109.794 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.8 mp0 -63.65 -26.91 68.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.37 -0.831 . . . . 0.0 110.35 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.95 146.5 67.91 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.06 -1.025 . . . . 0.0 109.966 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -50.49 150.6 11.38 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.652 2.235 . . . . 0.0 112.079 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.7 p -58.83 -21.16 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 0.0 110.21 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.95 -37.06 86.02 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.0 -1.063 . . . . 0.0 108.637 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -64.26 -39.81 94.71 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.1 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.2 tp -63.28 -39.98 96.09 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.348 -0.845 . . . . 0.0 109.513 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 84.2 mt -57.88 -48.89 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.22 -0.925 . . . . 0.0 109.482 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.586 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 1.3 ttm105 -55.63 -38.96 70.19 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.207 -0.933 . . . . 0.0 109.007 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.43 ' CD1' ' HG3' ' A' ' 6' ' ' PRO . 86.8 t80 -59.44 -45.46 91.51 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.176 -0.952 . . . . 0.0 109.109 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -62.69 -41.34 99.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.408 -0.808 . . . . 0.0 110.077 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.789 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 26.0 p30 -63.9 -33.84 76.6 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.109 -0.994 . . . . 0.0 109.997 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.789 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 78.2 m-20 -67.39 -42.72 82.87 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.909 -1.119 . . . . 0.0 108.494 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.6 tp -62.69 -38.22 89.57 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -58.35 -40.29 81.79 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -62.56 -38.36 89.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.317 -0.864 . . . . 0.0 108.976 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -55.45 -51.25 67.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.471 -0.768 . . . . 0.0 109.604 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 79.3 mt -67.27 -36.21 81.11 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.544 -0.723 . . . . 0.0 109.369 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -61.09 -44.13 97.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.499 -0.751 . . . . 0.0 110.472 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.579 ' O ' ' OXT' ' A' ' 30' ' ' VAL . 35.5 m -76.35 -30.58 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.078 -1.014 . . . . 0.0 109.887 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.579 ' OXT' ' O ' ' A' ' 29' ' ' VAL . 43.6 t . . . . . 0 C--N 1.302 -1.489 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.584 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.711 ' O ' ' CE2' ' A' ' 26' ' ' TYR . 3.1 Cg_exo . . . . . 0 C--O 1.213 -0.751 0 N-CA-C 109.732 -0.911 . . . . 0.0 109.732 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.731 ' CG ' ' O ' ' A' ' 2' ' ' PHE . 21.4 p90 -131.24 98.12 19.05 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.259 -0.901 . . . . 0.0 109.357 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.531 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 3.8 Cg_exo -61.0 -42.47 36.56 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 122.41 2.073 . . . . 0.0 114.181 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 3' ' ' PRO . 3.0 Cg_exo -62.62 144.42 94.22 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.034 1.823 . . . . 0.0 112.559 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.62 125.57 36.94 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.317 -0.865 . . . . 0.0 108.913 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -56.51 151.05 48.06 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.809 1.672 . . . . 0.0 112.494 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -69.05 174.62 8.63 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.144 1.896 . . . . 0.0 111.86 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.21 172.88 54.84 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 55.6 mp0 -67.09 -44.96 78.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.992 -1.299 . . . . 0.0 110.012 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -83.71 -2.97 57.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.208 -0.933 . . . . 0.0 109.549 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.34 143.16 93.19 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 109.776 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -52.36 149.26 23.44 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.569 2.179 . . . . 0.0 112.276 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 m -65.55 -23.5 32.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.437 -0.79 . . . . 0.0 109.265 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -61.71 -36.3 80.54 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -61.05 -39.84 91.36 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.704 -0.798 . . . . 0.0 109.024 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.7 tt -61.15 -39.85 91.62 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.0 mt -63.25 -42.83 97.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -57.57 -38.55 74.99 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.465 ' CE2' ' HB2' ' A' ' 4' ' ' PRO . 37.6 t80 -58.78 -41.57 86.96 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.37 -0.831 . . . . 0.0 108.795 178.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -58.77 -44.41 90.62 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.447 -0.783 . . . . 0.0 109.759 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.791 ' ND2' ' N ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -64.41 -38.55 91.42 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.044 -1.035 . . . . 0.0 109.397 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.791 ' N ' ' ND2' ' A' ' 21' ' ' ASN . 48.6 t0 -64.33 -29.78 70.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.139 -0.976 . . . . 0.0 109.117 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.7 tt -68.83 -38.71 80.01 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.081 -1.012 . . . . 0.0 108.593 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -59.14 -45.94 89.65 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.468 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 44.9 tt0 -63.55 -34.18 77.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.944 . . . . 0.0 108.749 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.711 ' CE2' ' O ' ' A' ' 1' ' ' PRO . 0.6 OUTLIER -64.4 -54.17 36.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.581 -0.699 . . . . 0.0 110.494 -179.572 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.8 mt -78.29 -37.01 45.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -0.992 . . . . 0.0 110.577 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -60.51 -42.31 96.13 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.149 -0.97 . . . . 0.0 111.03 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.468 ' CG2' ' O ' ' A' ' 25' ' ' GLN . 35.2 m -71.08 -29.93 38.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 C--N 1.303 -1.434 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.837 179.099 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo . . . . . 0 N--CA 1.48 0.735 0 N-CA-C 110.0 -0.808 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.687 ' CG ' ' O ' ' A' ' 2' ' ' PHE . 4.6 p90 -115.69 108.15 47.44 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.419 -0.8 . . . . 0.0 109.114 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.535 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 3.7 Cg_exo -60.04 -42.06 47.26 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.425 2.083 . . . . 0.0 113.915 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.565 ' O ' ' CE2' ' A' ' 2' ' ' PHE . 3.5 Cg_exo -63.04 127.84 21.37 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 121.908 1.739 . . . . 0.0 112.109 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.575 ' O ' ' CE2' ' A' ' 19' ' ' PHE . 30.0 m -118.12 109.58 40.7 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -56.16 149.76 52.29 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.333 1.355 . . . . 0.0 112.908 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.428 ' CG ' ' OD1' ' A' ' 15' ' ' ASP . 2.4 Cg_endo -65.51 164.91 24.43 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.624 2.216 . . . . 0.0 112.008 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.3 174.16 55.24 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -66.27 -37.59 85.83 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.015 -1.285 . . . . 0.0 110.173 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.79 -31.83 71.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.299 -0.876 . . . . 0.0 110.42 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.34 147.91 94.27 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.917 . . . . 0.0 110.255 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.614 ' O ' ' OD1' ' A' ' 15' ' ' ASP . 2.9 Cg_endo -50.55 144.95 23.66 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.855 2.37 . . . . 0.0 112.271 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.7 p -65.8 -20.62 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.442 -0.786 . . . . 0.0 110.451 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 57.8 mp0 -63.23 -39.26 94.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.886 -1.134 . . . . 0.0 109.439 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.733 ' OD1' ' N ' ' A' ' 16' ' ' LEU . 46.8 p30 -63.72 -36.72 84.8 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.127 -0.983 . . . . 0.0 109.202 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.733 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 1.1 tp -64.48 -39.16 93.27 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.279 -0.888 . . . . 0.0 109.251 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 97.0 mt -57.43 -50.81 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.452 -0.78 . . . . 0.0 110.023 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.588 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 0.2 OUTLIER -60.63 -41.4 94.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.018 -1.051 . . . . 0.0 110.128 -179.568 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.575 ' CE2' ' O ' ' A' ' 5' ' ' THR . 7.0 m-85 -67.79 -36.51 80.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.87 -1.144 . . . . 0.0 109.189 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -57.01 -39.46 74.78 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.809 ' ND2' ' N ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -66.7 -43.13 85.2 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.109 179.454 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.809 ' N ' ' ND2' ' A' ' 21' ' ' ASN . 93.9 m-20 -60.34 -37.26 80.07 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.447 HD23 ' N ' ' A' ' 23' ' ' LEU . 4.0 mm? -64.74 -36.38 84.1 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -53.67 -42.22 67.67 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.664 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 97.5 mt-30 -67.79 -38.32 83.2 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.41 ' HB3' ' O ' ' A' ' 23' ' ' LEU . 88.7 t80 -55.85 -48.24 75.85 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.609 -0.682 . . . . 0.0 109.983 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 36.4 mt -62.76 -49.98 72.85 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.483 -0.76 . . . . 0.0 110.283 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -69.13 -36.2 77.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.831 -1.168 . . . . 0.0 108.359 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.664 ' CG2' ' O ' ' A' ' 25' ' ' GLN . 62.4 t -65.78 -37.8 80.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.492 ' O ' ' O ' ' A' ' 29' ' ' VAL . 74.0 t . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.359 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo . . . . . 0 N--CA 1.48 0.714 0 N-CA-C 109.762 -0.899 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -130.99 143.08 47.95 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.116 -0.99 . . . . 0.0 109.373 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.73 132.96 32.28 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 121.863 1.709 . . . . 0.0 112.216 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -59.7 150.28 77.77 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.139 1.893 . . . . 0.0 111.625 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 m -123.46 79.28 54.35 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.134 -0.979 . . . . 0.0 109.352 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.486 ' HG3' ' CE1' ' A' ' 19' ' ' PHE . 2.4 Cg_endo -57.44 152.39 47.4 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.028 1.818 . . . . 0.0 112.362 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -73.28 -147.41 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.184 0 C-N-CA 121.816 1.677 . . . . 0.0 111.378 178.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -83.93 175.23 51.67 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -66.84 -37.67 84.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.111 -1.229 . . . . 0.0 110.089 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.486 ' O ' ' C ' ' A' ' 11' ' ' ALA . 96.9 mt-10 -67.6 -26.98 66.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.319 -0.863 . . . . 0.0 110.519 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.486 ' C ' ' O ' ' A' ' 10' ' ' GLU . . . -36.88 150.61 0.13 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.069 -1.019 . . . . 0.0 110.075 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -50.26 149.15 12.88 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.926 2.417 . . . . 0.0 111.934 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 m -65.47 -19.64 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.157 -0.964 . . . . 0.0 109.459 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.16 -38.14 89.99 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -65.83 -38.77 89.81 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.159 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.3 tp -60.99 -42.73 98.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.319 -0.863 . . . . 0.0 109.329 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 72.5 mt -59.8 -49.23 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.41 -0.806 . . . . 0.0 109.433 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.699 ' HE ' ' N ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -55.68 -35.45 66.03 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.442 -0.786 . . . . 0.0 109.036 179.695 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.699 ' N ' ' HE ' ' A' ' 18' ' ' ARG . 93.9 t80 -61.67 -52.03 66.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.214 -0.928 . . . . 0.0 108.935 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -58.74 -39.44 80.9 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -60.86 -45.12 95.81 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -69.44 -39.32 77.89 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.565 -0.71 . . . . 0.0 109.715 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.2 tp -58.37 -43.18 88.32 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.242 -0.912 . . . . 0.0 108.934 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.455 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 53.5 tt0 -61.09 -39.72 91.0 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.463 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 47.4 tt0 -59.85 -40.0 87.08 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.502 -0.749 . . . . 0.0 109.202 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -66.47 -51.22 59.14 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.341 -0.849 . . . . 0.0 110.434 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.404 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 60.8 mt -74.85 -38.97 61.84 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 110.245 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 24' ' ' GLN . 27.9 t30 -60.28 -43.06 96.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.334 -0.854 . . . . 0.0 110.885 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.463 ' CG2' ' O ' ' A' ' 25' ' ' GLN . 25.2 m -72.41 -30.58 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 120.913 -1.117 . . . . 0.0 108.727 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 27' ' ' LEU . 78.1 t . . . . . 0 C--N 1.304 -1.411 0 CA-C-O 118.066 -0.968 . . . . 0.0 109.812 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo . . . . . 0 N--CA 1.48 0.722 0 N-CA-C 109.681 -0.93 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.728 ' CG ' ' O ' ' A' ' 2' ' ' PHE . 11.4 p90 -114.78 101.82 54.58 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.368 -0.833 . . . . 0.0 109.188 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.509 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 3.5 Cg_exo -61.41 -42.67 32.59 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.608 2.205 . . . . 0.0 114.118 -178.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.509 ' CD ' ' N ' ' A' ' 3' ' ' PRO . 3.9 Cg_exo -62.65 130.98 31.53 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.967 1.778 . . . . 0.0 112.458 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 t -126.27 86.88 57.27 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 109.072 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.474 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 3.0 Cg_exo -55.67 151.58 38.55 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.585 1.523 . . . . 0.0 112.138 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.551 ' CD ' ' OD1' ' A' ' 15' ' ' ASP . 2.8 Cg_endo -58.89 -69.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.589 2.192 . . . . 0.0 111.984 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.89 175.7 40.94 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.14 -33.64 75.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.382 -1.069 . . . . 0.0 110.082 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -58.66 -32.62 69.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -0.931 . . . . 0.0 109.736 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.88 149.49 92.63 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.245 -0.909 . . . . 0.0 109.851 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -50.0 146.55 16.76 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.741 2.294 . . . . 0.0 111.99 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.11 -18.3 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.325 -0.859 . . . . 0.0 110.205 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.79 -36.21 82.39 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 120.974 -1.078 . . . . 0.0 109.16 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.551 ' OD1' ' CD ' ' A' ' 7' ' ' PRO . 13.3 t70 -61.94 -41.54 98.09 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.573 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 45.0 mt -65.58 -36.63 84.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.001 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.444 HD11 HG22 ' A' ' 17' ' ' ILE . 71.7 mt -59.43 -49.62 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.072 -1.018 . . . . 0.0 110.146 -179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.508 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 22.9 mtp180 -62.58 -42.03 99.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.651 -1.281 . . . . 0.0 109.471 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.474 ' CE2' ' HA ' ' A' ' 6' ' ' PRO . 6.9 m-85 -61.18 -34.64 75.38 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -58.01 -38.15 75.62 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -59.35 -45.96 89.96 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.028 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -61.79 -37.49 84.56 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.9 mt -62.73 -36.74 83.98 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.498 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 63.5 tt0 -58.93 -47.67 84.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.354 -0.842 . . . . 0.0 108.926 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.537 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 61.1 tt0 -63.7 -41.35 98.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.169 -0.957 . . . . 0.0 108.92 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.618 ' CD1' ' C ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -66.03 -51.68 56.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.609 -0.682 . . . . 0.0 110.071 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.457 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 89.4 mt -74.08 -38.47 63.89 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.918 -1.114 . . . . 0.0 110.325 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 24' ' ' GLN . 25.3 t30 -62.83 -42.58 99.79 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.991 -1.068 . . . . 0.0 110.56 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 25' ' ' GLN . 31.3 m -76.85 -31.09 18.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 120.92 -1.113 . . . . 0.0 108.778 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.502 ' O ' ' O ' ' A' ' 29' ' ' VAL . 76.9 t . . . . . 0 C--N 1.304 -1.394 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.696 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo . . . . . 0 N--CA 1.483 0.897 0 N-CA-C 110.013 -0.803 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.751 ' CG ' ' O ' ' A' ' 2' ' ' PHE . 8.6 p90 -127.16 87.15 57.17 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.104 -0.997 . . . . 0.0 109.478 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.523 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 4.1 Cg_exo -61.35 -43.65 27.27 Favored 'Trans proline' 0 C--N 1.299 -2.056 0 C-N-CA 122.619 2.212 . . . . 0.0 114.079 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' A' ' 3' ' ' PRO . 3.2 Cg_exo -64.41 140.75 71.3 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.324 2.016 . . . . 0.0 112.514 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.64 144.21 30.95 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.298 -0.876 . . . . 0.0 108.919 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -56.0 151.07 43.74 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.104 1.869 . . . . 0.0 111.986 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -79.03 168.02 21.17 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.199 1.933 . . . . 0.0 111.885 178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.37 155.89 53.18 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -60.88 -38.93 87.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.885 -1.362 . . . . 0.0 109.346 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -71.73 -24.75 61.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.466 -0.772 . . . . 0.0 109.993 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.76 142.42 16.43 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.131 -0.981 . . . . 0.0 110.022 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -52.71 148.34 28.43 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.605 2.204 . . . . 0.0 112.073 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.02 -23.17 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.296 -0.877 . . . . 0.0 109.734 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.67 -33.5 75.76 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 120.954 -1.092 . . . . 0.0 108.435 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -61.3 -40.34 93.8 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.468 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.523 HD12 ' H ' ' A' ' 16' ' ' LEU . 6.6 mp -62.19 -41.3 98.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.131 -0.981 . . . . 0.0 108.735 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.2 mt -58.97 -44.25 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.427 -0.909 . . . . 0.0 108.684 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.453 ' HG3' ' ND2' ' A' ' 21' ' ' ASN . 18.9 ttm180 -61.69 -38.62 88.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.391 -0.818 . . . . 0.0 109.446 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -55.74 -46.36 77.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.261 -0.899 . . . . 0.0 108.889 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -61.68 -39.19 90.55 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.569 ' ND2' ' OD1' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -60.0 -44.46 94.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.408 -0.808 . . . . 0.0 109.344 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.569 ' OD1' ' ND2' ' A' ' 21' ' ' ASN . 89.9 m-20 -59.51 -40.74 88.09 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.285 -0.885 . . . . 0.0 109.718 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 38.0 tp -60.07 -41.07 91.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.023 -1.048 . . . . 0.0 108.959 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.446 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 46.1 tt0 -60.81 -38.46 85.46 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.522 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 61.8 tp60 -60.58 -40.21 90.91 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.393 -0.817 . . . . 0.0 108.953 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.442 ' CD1' ' C ' ' A' ' 26' ' ' TYR . 25.2 t80 -69.02 -52.54 27.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.348 -0.845 . . . . 0.0 110.079 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.48 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 78.2 mt -70.16 -37.53 75.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.358 -0.839 . . . . 0.0 110.237 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 24' ' ' GLN . 29.1 t30 -68.29 -41.29 81.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.117 -0.989 . . . . 0.0 110.83 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 25' ' ' GLN . 17.3 m -78.99 -35.19 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 120.974 -1.079 . . . . 0.0 109.49 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.48 ' CG2' ' O ' ' A' ' 27' ' ' LEU . 25.1 t . . . . . 0 C--N 1.302 -1.472 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.607 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . 0.426 ' H2 ' ' H ' ' A' ' 2' ' ' PHE . 2.6 Cg_endo . . . . . 0 N--CA 1.481 0.764 0 N-CA-C 109.612 -0.957 . . . . 0.0 109.612 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.712 ' CE2' ' O ' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -136.72 128.77 17.08 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.182 -0.949 . . . . 0.0 109.377 179.737 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.505 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 3.5 Cg_exo -57.55 -43.52 50.2 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 122.405 2.07 . . . . 0.0 114.018 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.712 ' O ' ' CE2' ' A' ' 2' ' ' PHE . 3.5 Cg_exo -59.7 140.89 95.68 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.693 1.595 . . . . 0.0 112.367 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.34 160.98 39.39 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -55.55 150.9 40.79 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 121.628 1.552 . . . . 0.0 111.799 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -79.29 -67.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.921 1.747 . . . . 0.0 112.296 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 145.26 148.12 4.76 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -57.88 -44.55 86.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.036 -1.273 . . . . 0.0 109.979 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -71.9 -29.14 64.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.912 . . . . 0.0 109.558 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -46.93 124.83 8.26 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.278 -0.889 . . . . 0.0 109.992 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.86 155.89 52.02 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 121.971 1.781 . . . . 0.0 111.688 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.9 p -56.01 -19.26 6.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.223 -0.923 . . . . 0.0 109.881 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -64.89 -41.93 95.2 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.987 -1.07 . . . . 0.0 108.545 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -67.03 -40.97 87.34 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.719 -0.792 . . . . 0.0 109.095 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.4 -38.53 87.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.391 -0.818 . . . . 0.0 109.091 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 54.2 mt -57.65 -53.83 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.423 -0.798 . . . . 0.0 110.209 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.698 ' HE ' ' C ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -55.59 -39.55 70.87 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.097 -1.002 . . . . 0.0 108.52 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.56 ' N ' ' HE ' ' A' ' 18' ' ' ARG . 13.3 t80 -62.42 -42.96 99.84 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.443 -0.786 . . . . 0.0 109.191 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -58.4 -43.49 88.58 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.481 -0.762 . . . . 0.0 109.541 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.766 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 28.1 p30 -69.06 -32.87 72.65 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.142 -0.974 . . . . 0.0 109.967 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.766 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 88.0 m-20 -63.55 -44.35 94.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.156 -0.965 . . . . 0.0 109.618 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.7 tp -65.87 -40.21 91.41 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.319 -0.863 . . . . 0.0 109.493 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.445 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 36.0 tt0 -60.39 -47.61 85.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 109.21 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.534 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 97.3 mt-30 -66.01 -33.47 75.88 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.21 -0.931 . . . . 0.0 108.844 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.566 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.8 OUTLIER -64.37 -55.75 19.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.465 -0.772 . . . . 0.0 110.363 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.2 mt -76.93 -38.81 52.67 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.093 -1.004 . . . . 0.0 110.381 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.445 ' CB ' ' O ' ' A' ' 24' ' ' GLN . 17.9 t30 -61.72 -43.12 99.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.152 -0.968 . . . . 0.0 110.74 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.575 ' O ' ' O ' ' A' ' 30' ' ' VAL . 15.7 m -71.76 -30.8 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 120.921 -1.112 . . . . 0.0 108.82 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.575 ' O ' ' O ' ' A' ' 29' ' ' VAL . 71.4 t . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.586 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.451 ' CG ' ' HD3' ' A' ' 4' ' ' PRO . 5.0 Cg_exo . . . . . 0 N--CA 1.486 1.061 0 N-CA-C 113.736 0.629 . . . . 0.0 113.736 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.451 ' HD3' ' CG ' ' A' ' 3' ' ' PRO . 3.1 Cg_exo -69.92 132.98 24.19 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.174 1.916 . . . . 0.0 112.444 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.7 m -110.25 125.22 31.44 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.462 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 3.0 Cg_exo -54.07 150.79 30.16 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.411 1.407 . . . . 0.0 112.024 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.61 163.76 21.27 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.448 2.099 . . . . 0.0 112.241 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.69 172.72 52.2 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -64.55 -36.39 84.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.038 -1.272 . . . . 0.0 109.57 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.92 -28.9 68.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.406 -0.809 . . . . 0.0 110.153 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.39 141.14 71.59 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.174 -0.954 . . . . 0.0 110.002 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -54.35 149.44 37.61 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.541 2.161 . . . . 0.0 112.258 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.9 p -60.71 -22.49 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.327 -0.858 . . . . 0.0 109.743 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.87 -34.39 77.28 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -61.42 -38.08 85.81 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.57 HD13 ' O ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -61.9 -42.23 98.84 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.329 -0.857 . . . . 0.0 108.795 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.3 mt -60.3 -46.52 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.124 -0.985 . . . . 0.0 108.812 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.454 ' HG2' ' NH1' ' A' ' 18' ' ' ARG . 8.5 tpp85 -61.52 -40.18 93.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -0.858 . . . . 0.0 109.444 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.462 ' CD1' ' HA ' ' A' ' 6' ' ' PRO . 62.8 t80 -57.18 -45.71 83.44 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.214 -0.928 . . . . 0.0 108.499 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -59.72 -40.08 86.82 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -61.11 -47.3 86.93 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.586 0.708 . . . . 0.0 109.203 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -66.73 -39.75 88.1 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.249 -0.907 . . . . 0.0 109.346 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 32.8 tp -60.2 -40.03 88.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.243 -0.911 . . . . 0.0 108.892 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -59.06 -39.98 83.72 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.855 ' O ' HG23 ' A' ' 29' ' ' VAL . 99.5 mm-40 -60.93 -38.74 86.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.395 -0.816 . . . . 0.0 108.918 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -55.45 -49.6 72.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.396 -0.815 . . . . 0.0 110.089 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.764 ' O ' HG23 ' A' ' 30' ' ' VAL . 64.9 mt -60.62 -48.9 79.74 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.313 -0.867 . . . . 0.0 109.934 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -67.4 -37.02 82.46 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.888 -1.133 . . . . 0.0 108.155 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 25' ' ' GLN . 71.4 t -67.97 -39.04 80.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 121.426 0.631 . . . . 0.0 109.445 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 27' ' ' LEU . 72.7 t . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.005 -0.997 . . . . 0.0 109.518 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.538 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 3.7 Cg_exo . . . . . 0 N--CA 1.49 1.267 0 N-CA-C 113.82 0.662 . . . . 0.0 113.82 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 3' ' ' PRO . 3.2 Cg_exo -64.21 139.21 65.11 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.228 1.952 . . . . 0.0 112.845 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.4 m -123.69 129.33 24.87 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.373 -0.829 . . . . 0.0 108.777 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -55.5 151.83 36.1 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 121.797 1.665 . . . . 0.0 112.471 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -76.51 166.14 27.87 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.333 2.022 . . . . 0.0 111.969 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.57 174.64 50.38 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -65.32 -36.58 84.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.102 -1.234 . . . . 0.0 109.843 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -66.56 -31.47 72.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.333 -0.854 . . . . 0.0 110.03 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.81 139.64 77.0 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.056 -1.027 . . . . 0.0 109.549 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -53.74 152.57 21.89 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.254 1.97 . . . . 0.0 111.884 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.0 m -64.36 -29.34 47.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.242 -0.911 . . . . 0.0 109.247 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -60.61 -36.04 77.63 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -59.58 -39.67 84.89 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.8 tt -60.54 -40.46 91.63 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.404 -0.81 . . . . 0.0 109.007 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.2 mt -58.34 -48.32 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.199 -0.938 . . . . 0.0 109.502 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.493 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 54.0 mtp180 -60.05 -38.01 81.53 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.15 -0.969 . . . . 0.0 109.19 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -54.88 -42.23 71.83 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -60.22 -38.67 84.08 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.735 ' ND2' ' N ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -58.63 -47.85 83.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.371 -0.831 . . . . 0.0 109.647 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.735 ' N ' ' ND2' ' A' ' 21' ' ' ASN . 93.0 m-20 -59.66 -38.53 81.71 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.117 -0.989 . . . . 0.0 108.887 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.6 tp -59.34 -38.42 80.33 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -59.16 -44.27 92.11 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.365 -0.834 . . . . 0.0 108.942 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.605 ' O ' HG22 ' A' ' 29' ' ' VAL . 58.2 tt0 -65.11 -37.0 86.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.385 -0.822 . . . . 0.0 109.398 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -57.21 -47.22 81.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.563 -0.71 . . . . 0.0 110.641 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.584 ' O ' HG23 ' A' ' 30' ' ' VAL . 76.3 mt -69.24 -39.85 78.26 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.198 -0.938 . . . . 0.0 110.114 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -63.99 -42.38 97.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.139 -0.976 . . . . 0.0 110.244 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 25' ' ' GLN . 21.6 m -79.31 -30.56 14.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 121.177 -0.952 . . . . 0.0 109.932 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 27' ' ' LEU . 41.1 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.424 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo . . . . . 0 N--CA 1.483 0.874 0 CA-C-O 120.986 0.328 . . . . 0.0 112.09 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -52.75 147.13 32.66 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.614 2.21 . . . . 0.0 112.129 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 5' ' ' THR . 3.0 t -125.41 79.59 66.63 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 108.985 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.489 ' HG3' ' CD1' ' A' ' 19' ' ' PHE . 2.7 Cg_endo -55.96 156.39 19.93 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.126 1.884 . . . . 0.0 111.98 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -69.31 -62.99 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 121.784 1.656 . . . . 0.0 111.79 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 167.91 173.29 35.8 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -62.67 -31.35 72.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -1.185 . . . . 0.0 109.974 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -60.21 -31.02 69.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.353 -0.842 . . . . 0.0 109.635 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.991 ' HB1' ' OD2' ' A' ' 15' ' ' ASP . . . -66.89 147.57 99.04 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.102 -0.999 . . . . 0.0 109.489 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -49.65 147.87 12.75 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.532 2.155 . . . . 0.0 112.079 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.02 -18.83 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.317 -0.864 . . . . 0.0 109.568 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.18 -34.84 75.7 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.991 ' OD2' ' HB1' ' A' ' 11' ' ' ALA . 90.1 m-20 -62.22 -39.34 92.45 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.1 tp -58.38 -41.12 84.12 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.8 mt -55.79 -49.97 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.365 -0.834 . . . . 0.0 109.486 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.746 ' HE ' ' C ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -54.36 -42.52 70.39 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.772 -1.205 . . . . 0.0 108.231 -179.542 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.55 ' N ' ' HE ' ' A' ' 18' ' ' ARG . 67.7 t80 -60.67 -37.47 81.68 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.399 -0.813 . . . . 0.0 108.924 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.765 ' CD1' ' N ' ' A' ' 21' ' ' ASN . 0.0 OUTLIER -56.27 -53.88 51.94 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.551 -0.718 . . . . 0.0 109.429 -179.448 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.765 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 1.7 p30 -66.12 -37.64 86.22 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.424 -0.798 . . . . 0.0 110.154 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.587 ' OD2' ' NE ' ' A' ' 18' ' ' ARG . 89.5 m-20 -62.48 -43.93 97.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.945 -1.097 . . . . 0.0 109.716 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.9 tp -66.12 -38.68 88.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 109.562 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -58.8 -46.05 88.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 109.472 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.42 ' O ' HG22 ' A' ' 29' ' ' VAL . 50.1 tt0 -64.25 -37.79 88.72 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.193 -0.942 . . . . 0.0 109.206 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -55.8 -44.32 77.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.522 -0.737 . . . . 0.0 110.261 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.573 ' O ' HG23 ' A' ' 30' ' ' VAL . 38.9 mt -68.45 -40.9 80.92 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.418 -0.801 . . . . 0.0 110.129 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -63.7 -39.8 95.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.245 -0.91 . . . . 0.0 110.289 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.554 ' O ' ' O ' ' A' ' 30' ' ' VAL . 32.8 m -77.03 -30.8 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 120.998 -1.063 . . . . 0.0 109.402 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 27' ' ' LEU . 69.0 t . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.554 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.58 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 3.2 Cg_exo . . . . . 0 CA--C 1.549 1.237 0 N-CA-C 115.057 1.137 . . . . 0.0 115.057 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 3' ' ' PRO . 3.2 Cg_exo -53.38 133.54 53.49 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.302 1.334 . . . . 0.0 112.883 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 5' ' ' THR . 2.3 t -126.34 86.19 58.65 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.421 ' HG3' ' CD1' ' A' ' 19' ' ' PHE . 3.0 Cg_endo -55.98 151.6 40.93 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 121.78 1.653 . . . . 0.0 112.201 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -65.68 -62.36 0.08 OUTLIER 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 121.917 1.745 . . . . 0.0 111.884 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.45 175.57 44.8 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -66.5 -34.93 79.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -1.097 . . . . 0.0 109.794 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.8 mp0 -63.65 -26.91 68.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.37 -0.831 . . . . 0.0 110.35 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.412 ' HB1' ' OD2' ' A' ' 15' ' ' ASP . . . -57.95 146.5 67.91 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.06 -1.025 . . . . 0.0 109.966 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -50.49 150.6 11.38 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.652 2.235 . . . . 0.0 112.079 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.7 p -58.83 -21.16 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 0.0 110.21 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.95 -37.06 86.02 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.0 -1.063 . . . . 0.0 108.637 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.412 ' OD2' ' HB1' ' A' ' 11' ' ' ALA . 89.7 m-20 -64.26 -39.81 94.71 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.1 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.2 tp -63.28 -39.98 96.09 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.348 -0.845 . . . . 0.0 109.513 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 84.2 mt -57.88 -48.89 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.22 -0.925 . . . . 0.0 109.482 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.586 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 1.3 ttm105 -55.63 -38.96 70.19 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.207 -0.933 . . . . 0.0 109.007 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.421 ' CD1' ' HG3' ' A' ' 6' ' ' PRO . 86.8 t80 -59.44 -45.46 91.51 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.176 -0.952 . . . . 0.0 109.109 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -62.69 -41.34 99.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.408 -0.808 . . . . 0.0 110.077 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.789 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 26.0 p30 -63.9 -33.84 76.6 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.109 -0.994 . . . . 0.0 109.997 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.789 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 78.2 m-20 -67.39 -42.72 82.87 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.909 -1.119 . . . . 0.0 108.494 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.6 tp -62.69 -38.22 89.57 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -58.35 -40.29 81.79 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.434 ' O ' HG22 ' A' ' 29' ' ' VAL . 50.9 tt0 -62.56 -38.36 89.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.317 -0.864 . . . . 0.0 108.976 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -55.45 -51.25 67.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.471 -0.768 . . . . 0.0 109.604 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.606 ' O ' HG23 ' A' ' 30' ' ' VAL . 79.3 mt -67.27 -36.21 81.11 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.544 -0.723 . . . . 0.0 109.369 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -61.09 -44.13 97.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.499 -0.751 . . . . 0.0 110.472 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.579 ' O ' ' OXT' ' A' ' 30' ' ' VAL . 35.5 m -76.35 -30.58 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.078 -1.014 . . . . 0.0 109.887 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 27' ' ' LEU . 43.6 t . . . . . 0 C--N 1.302 -1.489 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.584 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.531 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 3.8 Cg_exo . . . . . 0 N--CA 1.488 1.186 0 N-CA-C 114.181 0.801 . . . . 0.0 114.181 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 3' ' ' PRO . 3.0 Cg_exo -62.62 144.42 94.22 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.034 1.823 . . . . 0.0 112.559 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.62 125.57 36.94 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.317 -0.865 . . . . 0.0 108.913 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -56.51 151.05 48.06 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.809 1.672 . . . . 0.0 112.494 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -69.05 174.62 8.63 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.144 1.896 . . . . 0.0 111.86 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.21 172.88 54.84 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 55.6 mp0 -67.09 -44.96 78.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.992 -1.299 . . . . 0.0 110.012 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -83.71 -2.97 57.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.208 -0.933 . . . . 0.0 109.549 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.34 143.16 93.19 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 109.776 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -52.36 149.26 23.44 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.569 2.179 . . . . 0.0 112.276 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 m -65.55 -23.5 32.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.437 -0.79 . . . . 0.0 109.265 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -61.71 -36.3 80.54 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -61.05 -39.84 91.36 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.704 -0.798 . . . . 0.0 109.024 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.7 tt -61.15 -39.85 91.62 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.0 mt -63.25 -42.83 97.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.406 ' HG3' ' OD1' ' A' ' 21' ' ' ASN . 8.9 ttm180 -57.57 -38.55 74.99 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.47 ' CE2' ' HB2' ' A' ' 4' ' ' PRO . 37.6 t80 -58.78 -41.57 86.96 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.37 -0.831 . . . . 0.0 108.795 178.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -58.77 -44.41 90.62 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.447 -0.783 . . . . 0.0 109.759 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.791 ' ND2' ' N ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -64.41 -38.55 91.42 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.044 -1.035 . . . . 0.0 109.397 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.791 ' N ' ' ND2' ' A' ' 21' ' ' ASN . 48.6 t0 -64.33 -29.78 70.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.139 -0.976 . . . . 0.0 109.117 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.7 tt -68.83 -38.71 80.01 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.081 -1.012 . . . . 0.0 108.593 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -59.14 -45.94 89.65 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.799 ' O ' HG22 ' A' ' 29' ' ' VAL . 44.9 tt0 -63.55 -34.18 77.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.944 . . . . 0.0 108.749 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.606 ' CD1' ' C ' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -64.4 -54.17 36.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.581 -0.699 . . . . 0.0 110.494 -179.572 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.433 ' HA ' HD23 ' A' ' 27' ' ' LEU . 93.8 mt -78.29 -37.01 45.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -0.992 . . . . 0.0 110.577 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -60.51 -42.31 96.13 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.149 -0.97 . . . . 0.0 111.03 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.799 HG22 ' O ' ' A' ' 25' ' ' GLN . 35.2 m -71.08 -29.93 38.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.43 ' O ' HG12 ' A' ' 30' ' ' VAL . 57.3 t . . . . . 0 C--N 1.303 -1.434 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.837 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.535 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 3.7 Cg_exo . . . . . 0 N--CA 1.489 1.211 0 N-CA-C 113.915 0.698 . . . . 0.0 113.915 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 3' ' ' PRO . 3.5 Cg_exo -63.04 127.84 21.37 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 121.908 1.739 . . . . 0.0 112.109 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.575 ' O ' ' CE2' ' A' ' 19' ' ' PHE . 30.0 m -118.12 109.58 40.7 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -56.16 149.76 52.29 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.333 1.355 . . . . 0.0 112.908 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.428 ' CG ' ' OD1' ' A' ' 15' ' ' ASP . 2.4 Cg_endo -65.51 164.91 24.43 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.624 2.216 . . . . 0.0 112.008 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.3 174.16 55.24 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -66.27 -37.59 85.83 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.015 -1.285 . . . . 0.0 110.173 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.79 -31.83 71.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.299 -0.876 . . . . 0.0 110.42 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.588 ' HB1' ' OD2' ' A' ' 15' ' ' ASP . . . -63.34 147.91 94.27 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.917 . . . . 0.0 110.255 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.614 ' O ' ' OD1' ' A' ' 15' ' ' ASP . 2.9 Cg_endo -50.55 144.95 23.66 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.855 2.37 . . . . 0.0 112.271 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.7 p -65.8 -20.62 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.442 -0.786 . . . . 0.0 110.451 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.533 ' HA ' HD12 ' A' ' 17' ' ' ILE . 57.8 mp0 -63.23 -39.26 94.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.886 -1.134 . . . . 0.0 109.439 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.733 ' OD1' ' N ' ' A' ' 16' ' ' LEU . 46.8 p30 -63.72 -36.72 84.8 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.127 -0.983 . . . . 0.0 109.202 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.733 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 1.1 tp -64.48 -39.16 93.27 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.279 -0.888 . . . . 0.0 109.251 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.533 HD12 ' HA ' ' A' ' 14' ' ' GLU . 97.0 mt -57.43 -50.81 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.452 -0.78 . . . . 0.0 110.023 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.735 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 0.2 OUTLIER -60.63 -41.4 94.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.018 -1.051 . . . . 0.0 110.128 -179.568 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.598 ' O ' HD23 ' A' ' 23' ' ' LEU . 7.0 m-85 -67.79 -36.51 80.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.87 -1.144 . . . . 0.0 109.189 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -57.01 -39.46 74.78 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.735 ' ND2' ' O ' ' A' ' 18' ' ' ARG . 5.7 p30 -66.7 -43.13 85.2 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.109 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.669 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 93.9 m-20 -60.34 -37.26 80.07 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.598 HD23 ' O ' ' A' ' 19' ' ' PHE . 4.0 mm? -64.74 -36.38 84.1 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -53.67 -42.22 67.67 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.854 ' O ' HG23 ' A' ' 29' ' ' VAL . 97.5 mt-30 -67.79 -38.32 83.2 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.428 ' HB3' ' O ' ' A' ' 23' ' ' LEU . 88.7 t80 -55.85 -48.24 75.85 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.609 -0.682 . . . . 0.0 109.983 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 30' ' ' VAL . 36.4 mt -62.76 -49.98 72.85 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.483 -0.76 . . . . 0.0 110.283 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -69.13 -36.2 77.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.831 -1.168 . . . . 0.0 108.359 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 25' ' ' GLN . 62.4 t -65.78 -37.8 80.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.492 ' O ' ' O ' ' A' ' 29' ' ' VAL . 74.0 t . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.359 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo . . . . . 0 N--CA 1.489 1.231 0 CA-C-O 120.667 0.195 . . . . 0.0 112.216 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -59.7 150.28 77.77 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.139 1.893 . . . . 0.0 111.625 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 m -123.46 79.28 54.35 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.134 -0.979 . . . . 0.0 109.352 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.491 ' HG3' ' CE1' ' A' ' 19' ' ' PHE . 2.4 Cg_endo -57.44 152.39 47.4 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.028 1.818 . . . . 0.0 112.362 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.557 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 2.6 Cg_endo -73.28 -147.41 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.184 0 C-N-CA 121.816 1.677 . . . . 0.0 111.378 178.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -83.93 175.23 51.67 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -66.84 -37.67 84.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.111 -1.229 . . . . 0.0 110.089 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.486 ' O ' ' C ' ' A' ' 11' ' ' ALA . 96.9 mt-10 -67.6 -26.98 66.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.319 -0.863 . . . . 0.0 110.519 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.557 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . . . -36.88 150.61 0.13 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.069 -1.019 . . . . 0.0 110.075 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -50.26 149.15 12.88 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.926 2.417 . . . . 0.0 111.934 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 m -65.47 -19.64 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.157 -0.964 . . . . 0.0 109.459 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.16 -38.14 89.99 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -65.83 -38.77 89.81 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.159 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.3 tp -60.99 -42.73 98.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.319 -0.863 . . . . 0.0 109.329 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 72.5 mt -59.8 -49.23 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.41 -0.806 . . . . 0.0 109.433 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.728 ' HE ' ' N ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -55.68 -35.45 66.03 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.442 -0.786 . . . . 0.0 109.036 179.695 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.728 ' N ' ' HE ' ' A' ' 18' ' ' ARG . 93.9 t80 -61.67 -52.03 66.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.214 -0.928 . . . . 0.0 108.935 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -58.74 -39.44 80.9 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -60.86 -45.12 95.81 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -69.44 -39.32 77.89 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.565 -0.71 . . . . 0.0 109.715 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.2 tp -58.37 -43.18 88.32 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.242 -0.912 . . . . 0.0 108.934 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.455 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 53.5 tt0 -61.09 -39.72 91.0 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.873 ' O ' HG22 ' A' ' 29' ' ' VAL . 47.4 tt0 -59.85 -40.0 87.08 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.502 -0.749 . . . . 0.0 109.202 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -66.47 -51.22 59.14 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.341 -0.849 . . . . 0.0 110.434 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.548 ' O ' HG23 ' A' ' 30' ' ' VAL . 60.8 mt -74.85 -38.97 61.84 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 110.245 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 24' ' ' GLN . 27.9 t30 -60.28 -43.06 96.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.334 -0.854 . . . . 0.0 110.885 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.873 HG22 ' O ' ' A' ' 25' ' ' GLN . 25.2 m -72.41 -30.58 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 120.913 -1.117 . . . . 0.0 108.727 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 27' ' ' LEU . 78.1 t . . . . . 0 C--N 1.304 -1.411 0 CA-C-O 118.066 -0.968 . . . . 0.0 109.812 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.509 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 3.5 Cg_exo . . . . . 0 N--CA 1.491 1.329 0 N-CA-C 114.118 0.776 . . . . 0.0 114.118 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.509 ' CD ' ' N ' ' A' ' 3' ' ' PRO . 3.9 Cg_exo -62.65 130.98 31.53 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.967 1.778 . . . . 0.0 112.458 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 5' ' ' THR . 3.3 t -126.27 86.88 57.27 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 109.072 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.454 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 3.0 Cg_exo -55.67 151.58 38.55 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.585 1.523 . . . . 0.0 112.138 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.551 ' CD ' ' OD1' ' A' ' 15' ' ' ASP . 2.8 Cg_endo -58.89 -69.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.589 2.192 . . . . 0.0 111.984 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.89 175.7 40.94 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.14 -33.64 75.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.382 -1.069 . . . . 0.0 110.082 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -58.66 -32.62 69.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -0.931 . . . . 0.0 109.736 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.88 149.49 92.63 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.245 -0.909 . . . . 0.0 109.851 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -50.0 146.55 16.76 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.741 2.294 . . . . 0.0 111.99 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.11 -18.3 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.325 -0.859 . . . . 0.0 110.205 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.79 -36.21 82.39 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 120.974 -1.078 . . . . 0.0 109.16 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.551 ' OD1' ' CD ' ' A' ' 7' ' ' PRO . 13.3 t70 -61.94 -41.54 98.09 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.573 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 45.0 mt -65.58 -36.63 84.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.001 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.7 mt -59.43 -49.62 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.072 -1.018 . . . . 0.0 110.146 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.508 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 22.9 mtp180 -62.58 -42.03 99.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.651 -1.281 . . . . 0.0 109.471 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.454 ' CE2' ' HA ' ' A' ' 6' ' ' PRO . 6.9 m-85 -61.18 -34.64 75.38 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -58.01 -38.15 75.62 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -59.35 -45.96 89.96 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.028 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -61.79 -37.49 84.56 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.428 HD23 ' HD2' ' A' ' 26' ' ' TYR . 5.9 mt -62.73 -36.74 83.98 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.498 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 63.5 tt0 -58.93 -47.67 84.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.354 -0.842 . . . . 0.0 108.926 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.925 ' O ' HG22 ' A' ' 29' ' ' VAL . 61.1 tt0 -63.7 -41.35 98.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.169 -0.957 . . . . 0.0 108.92 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.618 ' CD1' ' C ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -66.03 -51.68 56.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.609 -0.682 . . . . 0.0 110.071 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.537 ' O ' HG23 ' A' ' 30' ' ' VAL . 89.4 mt -74.08 -38.47 63.89 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.918 -1.114 . . . . 0.0 110.325 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 24' ' ' GLN . 25.3 t30 -62.83 -42.58 99.79 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.991 -1.068 . . . . 0.0 110.56 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.925 HG22 ' O ' ' A' ' 25' ' ' GLN . 31.3 m -76.85 -31.09 18.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 120.92 -1.113 . . . . 0.0 108.778 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 27' ' ' LEU . 76.9 t . . . . . 0 C--N 1.304 -1.394 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.696 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.523 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 4.1 Cg_exo . . . . . 0 N--CA 1.488 1.193 0 N-CA-C 114.079 0.761 . . . . 0.0 114.079 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' A' ' 3' ' ' PRO . 3.2 Cg_exo -64.41 140.75 71.3 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.324 2.016 . . . . 0.0 112.514 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.64 144.21 30.95 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.298 -0.876 . . . . 0.0 108.919 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 2.5 Cg_endo -56.0 151.07 43.74 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.104 1.869 . . . . 0.0 111.986 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 2.4 Cg_endo -79.03 168.02 21.17 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.199 1.933 . . . . 0.0 111.885 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.37 155.89 53.18 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -60.88 -38.93 87.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.885 -1.362 . . . . 0.0 109.346 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -71.73 -24.75 61.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.466 -0.772 . . . . 0.0 109.993 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.76 142.42 16.43 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.131 -0.981 . . . . 0.0 110.022 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -52.71 148.34 28.43 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.605 2.204 . . . . 0.0 112.073 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.02 -23.17 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.296 -0.877 . . . . 0.0 109.734 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.67 -33.5 75.76 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 120.954 -1.092 . . . . 0.0 108.435 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -61.3 -40.34 93.8 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.468 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.6 mp -62.19 -41.3 98.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.131 -0.981 . . . . 0.0 108.735 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.2 mt -58.97 -44.25 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.427 -0.909 . . . . 0.0 108.684 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.476 ' HG3' ' ND2' ' A' ' 21' ' ' ASN . 18.9 ttm180 -61.69 -38.62 88.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.391 -0.818 . . . . 0.0 109.446 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -55.74 -46.36 77.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.261 -0.899 . . . . 0.0 108.889 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -61.68 -39.19 90.55 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.569 ' ND2' ' OD1' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -60.0 -44.46 94.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.408 -0.808 . . . . 0.0 109.344 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.569 ' OD1' ' ND2' ' A' ' 21' ' ' ASN . 89.9 m-20 -59.51 -40.74 88.09 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.285 -0.885 . . . . 0.0 109.718 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 38.0 tp -60.07 -41.07 91.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.023 -1.048 . . . . 0.0 108.959 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.446 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 46.1 tt0 -60.81 -38.46 85.46 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.84 ' O ' HG22 ' A' ' 29' ' ' VAL . 8.9 tp-100 -60.58 -40.21 90.91 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.393 -0.817 . . . . 0.0 108.953 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.442 ' CD1' ' C ' ' A' ' 26' ' ' TYR . 25.2 t80 -69.02 -52.54 27.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.348 -0.845 . . . . 0.0 110.079 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.48 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 78.2 mt -70.16 -37.53 75.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.358 -0.839 . . . . 0.0 110.237 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 24' ' ' GLN . 29.1 t30 -68.29 -41.29 81.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.117 -0.989 . . . . 0.0 110.83 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.84 HG22 ' O ' ' A' ' 25' ' ' GLN . 17.3 m -78.99 -35.19 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 120.974 -1.079 . . . . 0.0 109.49 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.48 ' CG2' ' O ' ' A' ' 27' ' ' LEU . 25.1 t . . . . . 0 C--N 1.302 -1.472 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.607 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.508 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 3.5 Cg_exo . . . . . 0 N--CA 1.49 1.293 0 N-CA-C 114.018 0.738 . . . . 0.0 114.018 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 3' ' ' PRO . 3.5 Cg_exo -59.7 140.89 95.68 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.693 1.595 . . . . 0.0 112.367 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.34 160.98 39.39 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -55.55 150.9 40.79 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 121.628 1.552 . . . . 0.0 111.799 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -79.29 -67.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.921 1.747 . . . . 0.0 112.296 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 145.26 148.12 4.76 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -57.88 -44.55 86.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.036 -1.273 . . . . 0.0 109.979 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -71.9 -29.14 64.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.912 . . . . 0.0 109.558 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -46.93 124.83 8.26 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.278 -0.889 . . . . 0.0 109.992 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.86 155.89 52.02 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 121.971 1.781 . . . . 0.0 111.688 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.9 p -56.01 -19.26 6.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.223 -0.923 . . . . 0.0 109.881 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -64.89 -41.93 95.2 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.987 -1.07 . . . . 0.0 108.545 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -67.03 -40.97 87.34 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.719 -0.792 . . . . 0.0 109.095 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.4 -38.53 87.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.391 -0.818 . . . . 0.0 109.091 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 54.2 mt -57.65 -53.83 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.423 -0.798 . . . . 0.0 110.209 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.73 ' HE ' ' C ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -55.59 -39.55 70.87 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.097 -1.002 . . . . 0.0 108.52 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.595 ' N ' ' HE ' ' A' ' 18' ' ' ARG . 13.3 t80 -62.42 -42.96 99.84 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.443 -0.786 . . . . 0.0 109.191 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -58.4 -43.49 88.58 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.481 -0.762 . . . . 0.0 109.541 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.766 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 28.1 p30 -69.06 -32.87 72.65 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.142 -0.974 . . . . 0.0 109.967 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.766 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 88.0 m-20 -63.55 -44.35 94.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.156 -0.965 . . . . 0.0 109.618 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.7 tp -65.87 -40.21 91.41 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.319 -0.863 . . . . 0.0 109.493 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.445 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 36.0 tt0 -60.39 -47.61 85.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 109.21 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.787 ' O ' HG22 ' A' ' 29' ' ' VAL . 97.3 mt-30 -66.01 -33.47 75.88 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.21 -0.931 . . . . 0.0 108.844 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.566 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.8 OUTLIER -64.37 -55.75 19.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.465 -0.772 . . . . 0.0 110.363 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.561 ' O ' HG23 ' A' ' 30' ' ' VAL . 96.2 mt -76.93 -38.81 52.67 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.093 -1.004 . . . . 0.0 110.381 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.445 ' CB ' ' O ' ' A' ' 24' ' ' GLN . 17.9 t30 -61.72 -43.12 99.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.152 -0.968 . . . . 0.0 110.74 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 25' ' ' GLN . 15.7 m -71.76 -30.8 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 120.921 -1.112 . . . . 0.0 108.82 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.575 ' O ' ' O ' ' A' ' 29' ' ' VAL . 71.4 t . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.586 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.48 0.734 0 N-CA-C 109.539 -0.985 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.747 ' CG ' ' O ' ' A' ' 2' ' ' PHE . 1.8 p90 -122.66 94.75 47.3 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.122 -0.986 . . . . 0.0 109.547 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.451 ' CG ' ' HD3' ' A' ' 4' ' ' PRO . 5.0 Cg_exo -61.01 -47.38 12.82 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.444 2.096 . . . . 0.0 113.736 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.451 ' HD3' ' CG ' ' A' ' 3' ' ' PRO . 3.1 Cg_exo -69.92 132.98 24.19 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.174 1.916 . . . . 0.0 112.444 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.7 m -110.25 125.22 31.44 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.462 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 3.0 Cg_exo -54.07 150.79 30.16 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.411 1.407 . . . . 0.0 112.024 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.61 163.76 21.27 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.448 2.099 . . . . 0.0 112.241 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.69 172.72 52.2 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -64.55 -36.39 84.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.038 -1.272 . . . . 0.0 109.57 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.92 -28.9 68.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.406 -0.809 . . . . 0.0 110.153 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.39 141.14 71.59 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.174 -0.954 . . . . 0.0 110.002 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -54.35 149.44 37.61 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.541 2.161 . . . . 0.0 112.258 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.9 p -60.71 -22.49 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.327 -0.858 . . . . 0.0 109.743 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.87 -34.39 77.28 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -61.42 -38.08 85.81 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.57 HD13 ' O ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -61.9 -42.23 98.84 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.329 -0.857 . . . . 0.0 108.795 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.3 mt -60.3 -46.52 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.124 -0.985 . . . . 0.0 108.812 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.454 ' HG2' ' NH1' ' A' ' 18' ' ' ARG . 8.5 tpp85 -61.52 -40.18 93.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -0.858 . . . . 0.0 109.444 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.462 ' CD1' ' HA ' ' A' ' 6' ' ' PRO . 62.8 t80 -57.18 -45.71 83.44 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.214 -0.928 . . . . 0.0 108.499 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -59.72 -40.08 86.82 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -61.11 -47.3 86.93 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.586 0.708 . . . . 0.0 109.203 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -66.73 -39.75 88.1 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.249 -0.907 . . . . 0.0 109.346 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 32.8 tp -60.2 -40.03 88.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.243 -0.911 . . . . 0.0 108.892 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -59.06 -39.98 83.72 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.855 ' O ' HG23 ' A' ' 29' ' ' VAL . 99.5 mm-40 -60.93 -38.74 86.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.395 -0.816 . . . . 0.0 108.918 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -55.45 -49.6 72.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.396 -0.815 . . . . 0.0 110.089 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.764 ' O ' HG23 ' A' ' 30' ' ' VAL . 64.9 mt -60.62 -48.9 79.74 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.313 -0.867 . . . . 0.0 109.934 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -67.4 -37.02 82.46 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.888 -1.133 . . . . 0.0 108.155 178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 25' ' ' GLN . 71.4 t -67.97 -39.04 80.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 121.426 0.631 . . . . 0.0 109.445 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 27' ' ' LEU . 72.7 t . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.005 -0.997 . . . . 0.0 109.518 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.481 0.749 0 N-CA-C 109.739 -0.908 . . . . 0.0 109.739 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.671 ' CG ' ' O ' ' A' ' 2' ' ' PHE . 2.5 p90 -58.76 112.21 4.7 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.188 -0.945 . . . . 0.0 109.547 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.538 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 3.7 Cg_exo -60.58 -42.36 40.61 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.497 2.131 . . . . 0.0 113.82 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.619 ' O ' ' CE2' ' A' ' 2' ' ' PHE . 3.2 Cg_exo -64.21 139.21 65.11 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.228 1.952 . . . . 0.0 112.845 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.4 m -123.69 129.33 24.87 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.373 -0.829 . . . . 0.0 108.777 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -55.5 151.83 36.1 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 121.797 1.665 . . . . 0.0 112.471 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -76.51 166.14 27.87 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.333 2.022 . . . . 0.0 111.969 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.57 174.64 50.38 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -65.32 -36.58 84.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.102 -1.234 . . . . 0.0 109.843 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -66.56 -31.47 72.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.333 -0.854 . . . . 0.0 110.03 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.81 139.64 77.0 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.056 -1.027 . . . . 0.0 109.549 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -53.74 152.57 21.89 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.254 1.97 . . . . 0.0 111.884 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.0 m -64.36 -29.34 47.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.242 -0.911 . . . . 0.0 109.247 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -60.61 -36.04 77.63 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -59.58 -39.67 84.89 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.8 tt -60.54 -40.46 91.63 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.404 -0.81 . . . . 0.0 109.007 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.2 mt -58.34 -48.32 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.199 -0.938 . . . . 0.0 109.502 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.493 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 54.0 mtp180 -60.05 -38.01 81.53 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.15 -0.969 . . . . 0.0 109.19 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -54.88 -42.23 71.83 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -60.22 -38.67 84.08 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.735 ' ND2' ' N ' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -58.63 -47.85 83.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.371 -0.831 . . . . 0.0 109.647 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.735 ' N ' ' ND2' ' A' ' 21' ' ' ASN . 93.0 m-20 -59.66 -38.53 81.71 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.117 -0.989 . . . . 0.0 108.887 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.6 tp -59.34 -38.42 80.33 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -59.16 -44.27 92.11 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.365 -0.834 . . . . 0.0 108.942 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.605 ' O ' HG22 ' A' ' 29' ' ' VAL . 58.2 tt0 -65.11 -37.0 86.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.385 -0.822 . . . . 0.0 109.398 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -57.21 -47.22 81.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.563 -0.71 . . . . 0.0 110.641 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.584 ' O ' HG23 ' A' ' 30' ' ' VAL . 76.3 mt -69.24 -39.85 78.26 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.198 -0.938 . . . . 0.0 110.114 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -63.99 -42.38 97.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.139 -0.976 . . . . 0.0 110.244 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 25' ' ' GLN . 21.6 m -79.31 -30.56 14.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 121.177 -0.952 . . . . 0.0 109.932 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 27' ' ' LEU . 41.1 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.424 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo . . . . . 0 N--CA 1.481 0.789 0 N-CA-C 109.721 -0.915 . . . . 0.0 109.721 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -53.57 153.77 7.33 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.314 -0.866 . . . . 0.0 109.856 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -72.61 144.86 40.69 Favored 'Trans proline' 0 C--N 1.32 -0.953 0 C-N-CA 121.448 1.432 . . . . 0.0 112.09 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -52.75 147.13 32.66 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.614 2.21 . . . . 0.0 112.129 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 5' ' ' THR . 3.0 t -125.41 79.59 66.63 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 108.985 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.489 ' HG3' ' CD1' ' A' ' 19' ' ' PHE . 2.7 Cg_endo -55.96 156.39 19.93 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.126 1.884 . . . . 0.0 111.98 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -69.31 -62.99 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 121.784 1.656 . . . . 0.0 111.79 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 167.91 173.29 35.8 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -62.67 -31.35 72.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -1.185 . . . . 0.0 109.974 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -60.21 -31.02 69.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.353 -0.842 . . . . 0.0 109.635 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.991 ' HB1' ' OD2' ' A' ' 15' ' ' ASP . . . -66.89 147.57 99.04 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.102 -0.999 . . . . 0.0 109.489 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -49.65 147.87 12.75 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.532 2.155 . . . . 0.0 112.079 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.02 -18.83 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.317 -0.864 . . . . 0.0 109.568 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.18 -34.84 75.7 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.991 ' OD2' ' HB1' ' A' ' 11' ' ' ALA . 90.1 m-20 -62.22 -39.34 92.45 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.1 tp -58.38 -41.12 84.12 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.8 mt -55.79 -49.97 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.365 -0.834 . . . . 0.0 109.486 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.746 ' HE ' ' C ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -54.36 -42.52 70.39 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.772 -1.205 . . . . 0.0 108.231 -179.542 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.55 ' N ' ' HE ' ' A' ' 18' ' ' ARG . 67.7 t80 -60.67 -37.47 81.68 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.399 -0.813 . . . . 0.0 108.924 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.765 ' CD1' ' N ' ' A' ' 21' ' ' ASN . 0.0 OUTLIER -56.27 -53.88 51.94 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.551 -0.718 . . . . 0.0 109.429 -179.448 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.765 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 1.7 p30 -66.12 -37.64 86.22 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.424 -0.798 . . . . 0.0 110.154 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.587 ' OD2' ' NE ' ' A' ' 18' ' ' ARG . 89.5 m-20 -62.48 -43.93 97.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.945 -1.097 . . . . 0.0 109.716 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.9 tp -66.12 -38.68 88.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 109.562 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -58.8 -46.05 88.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 109.472 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.42 ' O ' HG22 ' A' ' 29' ' ' VAL . 50.1 tt0 -64.25 -37.79 88.72 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.193 -0.942 . . . . 0.0 109.206 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -55.8 -44.32 77.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.522 -0.737 . . . . 0.0 110.261 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.573 ' O ' HG23 ' A' ' 30' ' ' VAL . 38.9 mt -68.45 -40.9 80.92 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.418 -0.801 . . . . 0.0 110.129 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -63.7 -39.8 95.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.245 -0.91 . . . . 0.0 110.289 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.554 ' O ' ' O ' ' A' ' 30' ' ' VAL . 32.8 m -77.03 -30.8 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 120.998 -1.063 . . . . 0.0 109.402 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 27' ' ' LEU . 69.0 t . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.554 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo . . . . . 0 N--CA 1.481 0.79 0 N-CA-C 109.862 -0.861 . . . . 0.0 109.862 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.691 ' CG ' ' O ' ' A' ' 2' ' ' PHE . 2.8 p90 -56.59 111.87 3.8 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 109.614 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.58 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 3.2 Cg_exo -64.59 -36.12 44.22 Favored 'Trans proline' 0 CA--C 1.549 1.237 0 C-N-CA 122.581 2.187 . . . . 0.0 115.057 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 3' ' ' PRO . 3.2 Cg_exo -53.38 133.54 53.49 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.302 1.334 . . . . 0.0 112.883 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 5' ' ' THR . 2.3 t -126.34 86.19 58.65 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.421 ' HG3' ' CD1' ' A' ' 19' ' ' PHE . 3.0 Cg_endo -55.98 151.6 40.93 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 121.78 1.653 . . . . 0.0 112.201 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -65.68 -62.36 0.08 OUTLIER 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 121.917 1.745 . . . . 0.0 111.884 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.45 175.57 44.8 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -66.5 -34.93 79.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -1.097 . . . . 0.0 109.794 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.8 mp0 -63.65 -26.91 68.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.37 -0.831 . . . . 0.0 110.35 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.412 ' HB1' ' OD2' ' A' ' 15' ' ' ASP . . . -57.95 146.5 67.91 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.06 -1.025 . . . . 0.0 109.966 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -50.49 150.6 11.38 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.652 2.235 . . . . 0.0 112.079 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.7 p -58.83 -21.16 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 0.0 110.21 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.95 -37.06 86.02 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.0 -1.063 . . . . 0.0 108.637 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.412 ' OD2' ' HB1' ' A' ' 11' ' ' ALA . 89.7 m-20 -64.26 -39.81 94.71 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.1 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.2 tp -63.28 -39.98 96.09 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.348 -0.845 . . . . 0.0 109.513 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 84.2 mt -57.88 -48.89 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.22 -0.925 . . . . 0.0 109.482 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.586 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 1.3 ttm105 -55.63 -38.96 70.19 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.207 -0.933 . . . . 0.0 109.007 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.421 ' CD1' ' HG3' ' A' ' 6' ' ' PRO . 86.8 t80 -59.44 -45.46 91.51 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.176 -0.952 . . . . 0.0 109.109 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -62.69 -41.34 99.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.408 -0.808 . . . . 0.0 110.077 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.789 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 26.0 p30 -63.9 -33.84 76.6 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.109 -0.994 . . . . 0.0 109.997 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.789 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 78.2 m-20 -67.39 -42.72 82.87 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.909 -1.119 . . . . 0.0 108.494 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.6 tp -62.69 -38.22 89.57 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -58.35 -40.29 81.79 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.434 ' O ' HG22 ' A' ' 29' ' ' VAL . 50.9 tt0 -62.56 -38.36 89.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.317 -0.864 . . . . 0.0 108.976 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -55.45 -51.25 67.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.471 -0.768 . . . . 0.0 109.604 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.606 ' O ' HG23 ' A' ' 30' ' ' VAL . 79.3 mt -67.27 -36.21 81.11 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.544 -0.723 . . . . 0.0 109.369 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -61.09 -44.13 97.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.499 -0.751 . . . . 0.0 110.472 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.579 ' O ' ' OXT' ' A' ' 30' ' ' VAL . 35.5 m -76.35 -30.58 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.078 -1.014 . . . . 0.0 109.887 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 27' ' ' LEU . 43.6 t . . . . . 0 C--N 1.302 -1.489 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.584 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PRO . . . . . 0.711 ' O ' ' CE2' ' A' ' 26' ' ' TYR . 3.1 Cg_exo . . . . . 0 C--O 1.213 -0.751 0 N-CA-C 109.732 -0.911 . . . . 0.0 109.732 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.731 ' CG ' ' O ' ' A' ' 2' ' ' PHE . 21.4 p90 -131.24 98.12 19.05 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.259 -0.901 . . . . 0.0 109.357 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.531 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 3.8 Cg_exo -61.0 -42.47 36.56 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 122.41 2.073 . . . . 0.0 114.181 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 3' ' ' PRO . 3.0 Cg_exo -62.62 144.42 94.22 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.034 1.823 . . . . 0.0 112.559 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.62 125.57 36.94 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.317 -0.865 . . . . 0.0 108.913 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -56.51 151.05 48.06 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.809 1.672 . . . . 0.0 112.494 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -69.05 174.62 8.63 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.144 1.896 . . . . 0.0 111.86 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.21 172.88 54.84 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 55.6 mp0 -67.09 -44.96 78.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.992 -1.299 . . . . 0.0 110.012 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -83.71 -2.97 57.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.208 -0.933 . . . . 0.0 109.549 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.34 143.16 93.19 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 109.776 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -52.36 149.26 23.44 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.569 2.179 . . . . 0.0 112.276 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 m -65.55 -23.5 32.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.437 -0.79 . . . . 0.0 109.265 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -61.71 -36.3 80.54 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -61.05 -39.84 91.36 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.704 -0.798 . . . . 0.0 109.024 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.7 tt -61.15 -39.85 91.62 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.0 mt -63.25 -42.83 97.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.406 ' HG3' ' OD1' ' A' ' 21' ' ' ASN . 8.9 ttm180 -57.57 -38.55 74.99 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.47 ' CE2' ' HB2' ' A' ' 4' ' ' PRO . 37.6 t80 -58.78 -41.57 86.96 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.37 -0.831 . . . . 0.0 108.795 178.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -58.77 -44.41 90.62 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.447 -0.783 . . . . 0.0 109.759 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.791 ' ND2' ' N ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -64.41 -38.55 91.42 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.044 -1.035 . . . . 0.0 109.397 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.791 ' N ' ' ND2' ' A' ' 21' ' ' ASN . 48.6 t0 -64.33 -29.78 70.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.139 -0.976 . . . . 0.0 109.117 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.7 tt -68.83 -38.71 80.01 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.081 -1.012 . . . . 0.0 108.593 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -59.14 -45.94 89.65 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.799 ' O ' HG22 ' A' ' 29' ' ' VAL . 44.9 tt0 -63.55 -34.18 77.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.944 . . . . 0.0 108.749 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.711 ' CE2' ' O ' ' A' ' 1' ' ' PRO . 0.6 OUTLIER -64.4 -54.17 36.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.581 -0.699 . . . . 0.0 110.494 -179.572 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.433 ' HA ' HD23 ' A' ' 27' ' ' LEU . 93.8 mt -78.29 -37.01 45.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -0.992 . . . . 0.0 110.577 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -60.51 -42.31 96.13 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.149 -0.97 . . . . 0.0 111.03 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.799 HG22 ' O ' ' A' ' 25' ' ' GLN . 35.2 m -71.08 -29.93 38.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.43 ' O ' HG12 ' A' ' 30' ' ' VAL . 57.3 t . . . . . 0 C--N 1.303 -1.434 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.837 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo . . . . . 0 N--CA 1.48 0.735 0 N-CA-C 110.0 -0.808 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.687 ' CG ' ' O ' ' A' ' 2' ' ' PHE . 4.6 p90 -115.69 108.15 47.44 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.419 -0.8 . . . . 0.0 109.114 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.535 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 3.7 Cg_exo -60.04 -42.06 47.26 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.425 2.083 . . . . 0.0 113.915 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.565 ' O ' ' CE2' ' A' ' 2' ' ' PHE . 3.5 Cg_exo -63.04 127.84 21.37 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 121.908 1.739 . . . . 0.0 112.109 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.575 ' O ' ' CE2' ' A' ' 19' ' ' PHE . 30.0 m -118.12 109.58 40.7 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -56.16 149.76 52.29 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.333 1.355 . . . . 0.0 112.908 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.428 ' CG ' ' OD1' ' A' ' 15' ' ' ASP . 2.4 Cg_endo -65.51 164.91 24.43 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.624 2.216 . . . . 0.0 112.008 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.3 174.16 55.24 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -66.27 -37.59 85.83 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.015 -1.285 . . . . 0.0 110.173 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.79 -31.83 71.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.299 -0.876 . . . . 0.0 110.42 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.588 ' HB1' ' OD2' ' A' ' 15' ' ' ASP . . . -63.34 147.91 94.27 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.917 . . . . 0.0 110.255 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.614 ' O ' ' OD1' ' A' ' 15' ' ' ASP . 2.9 Cg_endo -50.55 144.95 23.66 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.855 2.37 . . . . 0.0 112.271 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.7 p -65.8 -20.62 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.442 -0.786 . . . . 0.0 110.451 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.533 ' HA ' HD12 ' A' ' 17' ' ' ILE . 57.8 mp0 -63.23 -39.26 94.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.886 -1.134 . . . . 0.0 109.439 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.733 ' OD1' ' N ' ' A' ' 16' ' ' LEU . 46.8 p30 -63.72 -36.72 84.8 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.127 -0.983 . . . . 0.0 109.202 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.733 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 1.1 tp -64.48 -39.16 93.27 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.279 -0.888 . . . . 0.0 109.251 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.533 HD12 ' HA ' ' A' ' 14' ' ' GLU . 97.0 mt -57.43 -50.81 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.452 -0.78 . . . . 0.0 110.023 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.735 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 0.2 OUTLIER -60.63 -41.4 94.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.018 -1.051 . . . . 0.0 110.128 -179.568 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.598 ' O ' HD23 ' A' ' 23' ' ' LEU . 7.0 m-85 -67.79 -36.51 80.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.87 -1.144 . . . . 0.0 109.189 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -57.01 -39.46 74.78 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.735 ' ND2' ' O ' ' A' ' 18' ' ' ARG . 5.7 p30 -66.7 -43.13 85.2 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.109 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.669 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 93.9 m-20 -60.34 -37.26 80.07 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.598 HD23 ' O ' ' A' ' 19' ' ' PHE . 4.0 mm? -64.74 -36.38 84.1 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -53.67 -42.22 67.67 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.854 ' O ' HG23 ' A' ' 29' ' ' VAL . 97.5 mt-30 -67.79 -38.32 83.2 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.428 ' HB3' ' O ' ' A' ' 23' ' ' LEU . 88.7 t80 -55.85 -48.24 75.85 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.609 -0.682 . . . . 0.0 109.983 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 30' ' ' VAL . 36.4 mt -62.76 -49.98 72.85 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.483 -0.76 . . . . 0.0 110.283 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -69.13 -36.2 77.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.831 -1.168 . . . . 0.0 108.359 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 25' ' ' GLN . 62.4 t -65.78 -37.8 80.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.492 ' O ' ' O ' ' A' ' 29' ' ' VAL . 74.0 t . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.359 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo . . . . . 0 N--CA 1.48 0.714 0 N-CA-C 109.762 -0.899 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -130.99 143.08 47.95 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.116 -0.99 . . . . 0.0 109.373 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.73 132.96 32.28 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 121.863 1.709 . . . . 0.0 112.216 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -59.7 150.28 77.77 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.139 1.893 . . . . 0.0 111.625 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 m -123.46 79.28 54.35 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.134 -0.979 . . . . 0.0 109.352 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.491 ' HG3' ' CE1' ' A' ' 19' ' ' PHE . 2.4 Cg_endo -57.44 152.39 47.4 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.028 1.818 . . . . 0.0 112.362 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.557 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 2.6 Cg_endo -73.28 -147.41 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.184 0 C-N-CA 121.816 1.677 . . . . 0.0 111.378 178.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -83.93 175.23 51.67 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -66.84 -37.67 84.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.111 -1.229 . . . . 0.0 110.089 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.486 ' O ' ' C ' ' A' ' 11' ' ' ALA . 96.9 mt-10 -67.6 -26.98 66.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.319 -0.863 . . . . 0.0 110.519 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.557 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . . . -36.88 150.61 0.13 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.069 -1.019 . . . . 0.0 110.075 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -50.26 149.15 12.88 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.926 2.417 . . . . 0.0 111.934 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 m -65.47 -19.64 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.157 -0.964 . . . . 0.0 109.459 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.16 -38.14 89.99 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -65.83 -38.77 89.81 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.159 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.3 tp -60.99 -42.73 98.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.319 -0.863 . . . . 0.0 109.329 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 72.5 mt -59.8 -49.23 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.41 -0.806 . . . . 0.0 109.433 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.728 ' HE ' ' N ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -55.68 -35.45 66.03 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.442 -0.786 . . . . 0.0 109.036 179.695 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.728 ' N ' ' HE ' ' A' ' 18' ' ' ARG . 93.9 t80 -61.67 -52.03 66.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.214 -0.928 . . . . 0.0 108.935 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -58.74 -39.44 80.9 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -60.86 -45.12 95.81 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -69.44 -39.32 77.89 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.565 -0.71 . . . . 0.0 109.715 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.2 tp -58.37 -43.18 88.32 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.242 -0.912 . . . . 0.0 108.934 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.455 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 53.5 tt0 -61.09 -39.72 91.0 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.873 ' O ' HG22 ' A' ' 29' ' ' VAL . 47.4 tt0 -59.85 -40.0 87.08 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.502 -0.749 . . . . 0.0 109.202 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -66.47 -51.22 59.14 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.341 -0.849 . . . . 0.0 110.434 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.548 ' O ' HG23 ' A' ' 30' ' ' VAL . 60.8 mt -74.85 -38.97 61.84 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 110.245 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 24' ' ' GLN . 27.9 t30 -60.28 -43.06 96.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.334 -0.854 . . . . 0.0 110.885 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.873 HG22 ' O ' ' A' ' 25' ' ' GLN . 25.2 m -72.41 -30.58 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 120.913 -1.117 . . . . 0.0 108.727 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 27' ' ' LEU . 78.1 t . . . . . 0 C--N 1.304 -1.411 0 CA-C-O 118.066 -0.968 . . . . 0.0 109.812 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo . . . . . 0 N--CA 1.48 0.722 0 N-CA-C 109.681 -0.93 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.728 ' CG ' ' O ' ' A' ' 2' ' ' PHE . 11.4 p90 -114.78 101.82 54.58 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.368 -0.833 . . . . 0.0 109.188 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.509 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 3.5 Cg_exo -61.41 -42.67 32.59 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.608 2.205 . . . . 0.0 114.118 -178.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.509 ' CD ' ' N ' ' A' ' 3' ' ' PRO . 3.9 Cg_exo -62.65 130.98 31.53 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.967 1.778 . . . . 0.0 112.458 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 5' ' ' THR . 3.3 t -126.27 86.88 57.27 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 109.072 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.454 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 3.0 Cg_exo -55.67 151.58 38.55 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.585 1.523 . . . . 0.0 112.138 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.551 ' CD ' ' OD1' ' A' ' 15' ' ' ASP . 2.8 Cg_endo -58.89 -69.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.589 2.192 . . . . 0.0 111.984 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.89 175.7 40.94 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.14 -33.64 75.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.382 -1.069 . . . . 0.0 110.082 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -58.66 -32.62 69.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -0.931 . . . . 0.0 109.736 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.88 149.49 92.63 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.245 -0.909 . . . . 0.0 109.851 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -50.0 146.55 16.76 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.741 2.294 . . . . 0.0 111.99 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.11 -18.3 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.325 -0.859 . . . . 0.0 110.205 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.79 -36.21 82.39 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 120.974 -1.078 . . . . 0.0 109.16 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.551 ' OD1' ' CD ' ' A' ' 7' ' ' PRO . 13.3 t70 -61.94 -41.54 98.09 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.573 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 45.0 mt -65.58 -36.63 84.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.001 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.7 mt -59.43 -49.62 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.072 -1.018 . . . . 0.0 110.146 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.508 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 22.9 mtp180 -62.58 -42.03 99.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.651 -1.281 . . . . 0.0 109.471 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.454 ' CE2' ' HA ' ' A' ' 6' ' ' PRO . 6.9 m-85 -61.18 -34.64 75.38 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -58.01 -38.15 75.62 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -59.35 -45.96 89.96 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.028 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -61.79 -37.49 84.56 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.428 HD23 ' HD2' ' A' ' 26' ' ' TYR . 5.9 mt -62.73 -36.74 83.98 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.498 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 63.5 tt0 -58.93 -47.67 84.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.354 -0.842 . . . . 0.0 108.926 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.925 ' O ' HG22 ' A' ' 29' ' ' VAL . 61.1 tt0 -63.7 -41.35 98.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.169 -0.957 . . . . 0.0 108.92 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.618 ' CD1' ' C ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -66.03 -51.68 56.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.609 -0.682 . . . . 0.0 110.071 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.537 ' O ' HG23 ' A' ' 30' ' ' VAL . 89.4 mt -74.08 -38.47 63.89 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.918 -1.114 . . . . 0.0 110.325 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 24' ' ' GLN . 25.3 t30 -62.83 -42.58 99.79 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.991 -1.068 . . . . 0.0 110.56 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.925 HG22 ' O ' ' A' ' 25' ' ' GLN . 31.3 m -76.85 -31.09 18.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 120.92 -1.113 . . . . 0.0 108.778 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 27' ' ' LEU . 76.9 t . . . . . 0 C--N 1.304 -1.394 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.696 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo . . . . . 0 N--CA 1.483 0.897 0 N-CA-C 110.013 -0.803 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.751 ' CG ' ' O ' ' A' ' 2' ' ' PHE . 8.6 p90 -127.16 87.15 57.17 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.104 -0.997 . . . . 0.0 109.478 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.523 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 4.1 Cg_exo -61.35 -43.65 27.27 Favored 'Trans proline' 0 C--N 1.299 -2.056 0 C-N-CA 122.619 2.212 . . . . 0.0 114.079 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' A' ' 3' ' ' PRO . 3.2 Cg_exo -64.41 140.75 71.3 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.324 2.016 . . . . 0.0 112.514 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.64 144.21 30.95 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.298 -0.876 . . . . 0.0 108.919 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 2.5 Cg_endo -56.0 151.07 43.74 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.104 1.869 . . . . 0.0 111.986 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 2.4 Cg_endo -79.03 168.02 21.17 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.199 1.933 . . . . 0.0 111.885 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.37 155.89 53.18 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -60.88 -38.93 87.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.885 -1.362 . . . . 0.0 109.346 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -71.73 -24.75 61.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.466 -0.772 . . . . 0.0 109.993 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.76 142.42 16.43 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.131 -0.981 . . . . 0.0 110.022 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -52.71 148.34 28.43 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.605 2.204 . . . . 0.0 112.073 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.02 -23.17 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.296 -0.877 . . . . 0.0 109.734 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.67 -33.5 75.76 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 120.954 -1.092 . . . . 0.0 108.435 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -61.3 -40.34 93.8 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.468 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.6 mp -62.19 -41.3 98.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.131 -0.981 . . . . 0.0 108.735 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.2 mt -58.97 -44.25 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.427 -0.909 . . . . 0.0 108.684 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.476 ' HG3' ' ND2' ' A' ' 21' ' ' ASN . 18.9 ttm180 -61.69 -38.62 88.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.391 -0.818 . . . . 0.0 109.446 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -55.74 -46.36 77.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.261 -0.899 . . . . 0.0 108.889 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -61.68 -39.19 90.55 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.569 ' ND2' ' OD1' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -60.0 -44.46 94.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.408 -0.808 . . . . 0.0 109.344 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.569 ' OD1' ' ND2' ' A' ' 21' ' ' ASN . 89.9 m-20 -59.51 -40.74 88.09 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.285 -0.885 . . . . 0.0 109.718 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 38.0 tp -60.07 -41.07 91.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.023 -1.048 . . . . 0.0 108.959 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.446 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 46.1 tt0 -60.81 -38.46 85.46 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.84 ' O ' HG22 ' A' ' 29' ' ' VAL . 8.9 tp-100 -60.58 -40.21 90.91 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.393 -0.817 . . . . 0.0 108.953 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.442 ' CD1' ' C ' ' A' ' 26' ' ' TYR . 25.2 t80 -69.02 -52.54 27.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.348 -0.845 . . . . 0.0 110.079 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.48 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 78.2 mt -70.16 -37.53 75.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.358 -0.839 . . . . 0.0 110.237 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 24' ' ' GLN . 29.1 t30 -68.29 -41.29 81.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.117 -0.989 . . . . 0.0 110.83 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.84 HG22 ' O ' ' A' ' 25' ' ' GLN . 17.3 m -78.99 -35.19 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 120.974 -1.079 . . . . 0.0 109.49 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.48 ' CG2' ' O ' ' A' ' 27' ' ' LEU . 25.1 t . . . . . 0 C--N 1.302 -1.472 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.607 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo . . . . . 0 N--CA 1.481 0.764 0 N-CA-C 109.612 -0.957 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.712 ' CE2' ' O ' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -136.72 128.77 17.08 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.182 -0.949 . . . . 0.0 109.377 179.737 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.508 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 3.5 Cg_exo -57.55 -43.52 50.2 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 122.405 2.07 . . . . 0.0 114.018 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.712 ' O ' ' CE2' ' A' ' 2' ' ' PHE . 3.5 Cg_exo -59.7 140.89 95.68 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.693 1.595 . . . . 0.0 112.367 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.34 160.98 39.39 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -55.55 150.9 40.79 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 121.628 1.552 . . . . 0.0 111.799 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -79.29 -67.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.921 1.747 . . . . 0.0 112.296 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 145.26 148.12 4.76 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -57.88 -44.55 86.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.036 -1.273 . . . . 0.0 109.979 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -71.9 -29.14 64.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.912 . . . . 0.0 109.558 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -46.93 124.83 8.26 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.278 -0.889 . . . . 0.0 109.992 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.86 155.89 52.02 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 121.971 1.781 . . . . 0.0 111.688 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.9 p -56.01 -19.26 6.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.223 -0.923 . . . . 0.0 109.881 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -64.89 -41.93 95.2 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.987 -1.07 . . . . 0.0 108.545 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -67.03 -40.97 87.34 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.719 -0.792 . . . . 0.0 109.095 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.4 -38.53 87.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.391 -0.818 . . . . 0.0 109.091 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 54.2 mt -57.65 -53.83 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.423 -0.798 . . . . 0.0 110.209 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.73 ' HE ' ' C ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -55.59 -39.55 70.87 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.097 -1.002 . . . . 0.0 108.52 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.595 ' N ' ' HE ' ' A' ' 18' ' ' ARG . 13.3 t80 -62.42 -42.96 99.84 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.443 -0.786 . . . . 0.0 109.191 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -58.4 -43.49 88.58 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.481 -0.762 . . . . 0.0 109.541 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.766 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 28.1 p30 -69.06 -32.87 72.65 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.142 -0.974 . . . . 0.0 109.967 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.766 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 88.0 m-20 -63.55 -44.35 94.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.156 -0.965 . . . . 0.0 109.618 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.7 tp -65.87 -40.21 91.41 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.319 -0.863 . . . . 0.0 109.493 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.445 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 36.0 tt0 -60.39 -47.61 85.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 109.21 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.787 ' O ' HG22 ' A' ' 29' ' ' VAL . 97.3 mt-30 -66.01 -33.47 75.88 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.21 -0.931 . . . . 0.0 108.844 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.566 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.8 OUTLIER -64.37 -55.75 19.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.465 -0.772 . . . . 0.0 110.363 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.561 ' O ' HG23 ' A' ' 30' ' ' VAL . 96.2 mt -76.93 -38.81 52.67 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.093 -1.004 . . . . 0.0 110.381 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.445 ' CB ' ' O ' ' A' ' 24' ' ' GLN . 17.9 t30 -61.72 -43.12 99.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.152 -0.968 . . . . 0.0 110.74 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 25' ' ' GLN . 15.7 m -71.76 -30.8 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 120.921 -1.112 . . . . 0.0 108.82 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.575 ' O ' ' O ' ' A' ' 29' ' ' VAL . 71.4 t . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.586 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.451 ' CG ' ' HD3' ' A' ' 4' ' ' PRO . 5.0 Cg_exo . . . . . 0 N--CA 1.486 1.061 0 N-CA-C 113.736 0.629 . . . . 0.0 113.736 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.451 ' HD3' ' CG ' ' A' ' 3' ' ' PRO . 3.1 Cg_exo -69.92 132.98 24.19 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.174 1.916 . . . . 0.0 112.444 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.7 m -110.25 125.22 31.44 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.462 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 3.0 Cg_exo -54.07 150.79 30.16 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.411 1.407 . . . . 0.0 112.024 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.61 163.76 21.27 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.448 2.099 . . . . 0.0 112.241 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.69 172.72 52.2 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -64.55 -36.39 84.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.038 -1.272 . . . . 0.0 109.57 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.92 -28.9 68.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.406 -0.809 . . . . 0.0 110.153 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.39 141.14 71.59 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.174 -0.954 . . . . 0.0 110.002 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -54.35 149.44 37.61 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.541 2.161 . . . . 0.0 112.258 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.9 p -60.71 -22.49 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.327 -0.858 . . . . 0.0 109.743 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.87 -34.39 77.28 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -61.42 -38.08 85.81 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.57 ' O ' HD13 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -61.9 -42.23 98.84 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.329 -0.857 . . . . 0.0 108.795 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.3 mt -60.3 -46.52 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.124 -0.985 . . . . 0.0 108.812 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.454 ' NH1' ' HG2' ' A' ' 18' ' ' ARG . 8.5 tpp85 -61.52 -40.18 93.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -0.858 . . . . 0.0 109.444 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.462 ' CD1' ' HA ' ' A' ' 6' ' ' PRO . 62.8 t80 -57.18 -45.71 83.44 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.214 -0.928 . . . . 0.0 108.499 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -59.72 -40.08 86.82 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -61.11 -47.3 86.93 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.586 0.708 . . . . 0.0 109.203 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -66.73 -39.75 88.1 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.249 -0.907 . . . . 0.0 109.346 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 32.8 tp -60.2 -40.03 88.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.243 -0.911 . . . . 0.0 108.892 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -59.06 -39.98 83.72 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.855 ' O ' HG23 ' A' ' 29' ' ' VAL . 99.5 mm-40 -60.93 -38.74 86.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.395 -0.816 . . . . 0.0 108.918 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -55.45 -49.6 72.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.396 -0.815 . . . . 0.0 110.089 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.764 ' O ' HG23 ' A' ' 30' ' ' VAL . 64.9 mt -60.62 -48.9 79.74 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.313 -0.867 . . . . 0.0 109.934 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.716 ' H ' HD22 ' A' ' 28' ' ' ASN . 0.7 OUTLIER -67.4 -37.02 82.46 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.888 -1.133 . . . . 0.0 108.155 178.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 25' ' ' GLN . 71.4 t -67.97 -39.04 80.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 121.426 0.631 . . . . 0.0 109.445 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 27' ' ' LEU . 72.7 t . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.005 -0.997 . . . . 0.0 109.518 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.538 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 3.7 Cg_exo . . . . . 0 N--CA 1.49 1.267 0 N-CA-C 113.82 0.662 . . . . 0.0 113.82 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 3' ' ' PRO . 3.2 Cg_exo -64.21 139.21 65.11 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.228 1.952 . . . . 0.0 112.845 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.4 m -123.69 129.33 24.87 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.373 -0.829 . . . . 0.0 108.777 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -55.5 151.83 36.1 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 121.797 1.665 . . . . 0.0 112.471 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -76.51 166.14 27.87 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.333 2.022 . . . . 0.0 111.969 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.57 174.64 50.38 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -65.32 -36.58 84.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.102 -1.234 . . . . 0.0 109.843 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -66.56 -31.47 72.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.333 -0.854 . . . . 0.0 110.03 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.81 139.64 77.0 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.056 -1.027 . . . . 0.0 109.549 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -53.74 152.57 21.89 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.254 1.97 . . . . 0.0 111.884 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.0 m -64.36 -29.34 47.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.242 -0.911 . . . . 0.0 109.247 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -60.61 -36.04 77.63 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -59.58 -39.67 84.89 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.8 tt -60.54 -40.46 91.63 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.404 -0.81 . . . . 0.0 109.007 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.2 mt -58.34 -48.32 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.199 -0.938 . . . . 0.0 109.502 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.642 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 54.0 mtp180 -60.05 -38.01 81.53 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.15 -0.969 . . . . 0.0 109.19 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -54.88 -42.23 71.83 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -60.22 -38.67 84.08 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.642 ' ND2' ' O ' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -58.63 -47.85 83.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.371 -0.831 . . . . 0.0 109.647 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.591 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 93.0 m-20 -59.66 -38.53 81.71 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.117 -0.989 . . . . 0.0 108.887 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.6 tp -59.34 -38.42 80.33 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -59.16 -44.27 92.11 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.365 -0.834 . . . . 0.0 108.942 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.605 ' O ' HG22 ' A' ' 29' ' ' VAL . 58.2 tt0 -65.11 -37.0 86.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.385 -0.822 . . . . 0.0 109.398 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -57.21 -47.22 81.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.563 -0.71 . . . . 0.0 110.641 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.584 ' O ' HG23 ' A' ' 30' ' ' VAL . 76.3 mt -69.24 -39.85 78.26 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.198 -0.938 . . . . 0.0 110.114 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.752 HD22 ' N ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -63.99 -42.38 97.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.139 -0.976 . . . . 0.0 110.244 -179.529 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 25' ' ' GLN . 21.6 m -79.31 -30.56 14.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 121.177 -0.952 . . . . 0.0 109.932 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 27' ' ' LEU . 41.1 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.424 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo . . . . . 0 N--CA 1.483 0.874 0 CA-C-O 120.986 0.328 . . . . 0.0 112.09 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -52.75 147.13 32.66 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.614 2.21 . . . . 0.0 112.129 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 5' ' ' THR . 3.0 t -125.41 79.59 66.63 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 108.985 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.489 ' HG3' ' CD1' ' A' ' 19' ' ' PHE . 2.7 Cg_endo -55.96 156.39 19.93 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.126 1.884 . . . . 0.0 111.98 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -69.31 -62.99 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 121.784 1.656 . . . . 0.0 111.79 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 167.91 173.29 35.8 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -62.67 -31.35 72.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -1.185 . . . . 0.0 109.974 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -60.21 -31.02 69.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.353 -0.842 . . . . 0.0 109.635 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.991 ' HB1' ' OD2' ' A' ' 15' ' ' ASP . . . -66.89 147.57 99.04 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.102 -0.999 . . . . 0.0 109.489 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -49.65 147.87 12.75 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.532 2.155 . . . . 0.0 112.079 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.02 -18.83 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.317 -0.864 . . . . 0.0 109.568 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.18 -34.84 75.7 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.991 ' OD2' ' HB1' ' A' ' 11' ' ' ALA . 90.1 m-20 -62.22 -39.34 92.45 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.1 tp -58.38 -41.12 84.12 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.8 mt -55.79 -49.97 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.365 -0.834 . . . . 0.0 109.486 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.746 ' HE ' ' C ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -54.36 -42.52 70.39 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.772 -1.205 . . . . 0.0 108.231 -179.542 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.55 ' N ' ' HE ' ' A' ' 18' ' ' ARG . 67.7 t80 -60.67 -37.47 81.68 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.399 -0.813 . . . . 0.0 108.924 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.765 ' CD1' ' N ' ' A' ' 21' ' ' ASN . 0.0 OUTLIER -56.27 -53.88 51.94 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.551 -0.718 . . . . 0.0 109.429 -179.448 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.765 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 1.7 p30 -66.12 -37.64 86.22 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.424 -0.798 . . . . 0.0 110.154 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.587 ' OD2' ' NE ' ' A' ' 18' ' ' ARG . 89.5 m-20 -62.48 -43.93 97.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.945 -1.097 . . . . 0.0 109.716 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.9 tp -66.12 -38.68 88.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 109.562 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -58.8 -46.05 88.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 109.472 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.42 ' O ' HG22 ' A' ' 29' ' ' VAL . 50.1 tt0 -64.25 -37.79 88.72 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.193 -0.942 . . . . 0.0 109.206 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -55.8 -44.32 77.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.522 -0.737 . . . . 0.0 110.261 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.573 ' O ' HG23 ' A' ' 30' ' ' VAL . 38.9 mt -68.45 -40.9 80.92 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.418 -0.801 . . . . 0.0 110.129 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.673 HD22 ' N ' ' A' ' 28' ' ' ASN . 0.8 OUTLIER -63.7 -39.8 95.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.245 -0.91 . . . . 0.0 110.289 -179.598 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.554 ' O ' ' O ' ' A' ' 30' ' ' VAL . 32.8 m -77.03 -30.8 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 120.998 -1.063 . . . . 0.0 109.402 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 27' ' ' LEU . 69.0 t . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.554 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.58 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 3.2 Cg_exo . . . . . 0 CA--C 1.549 1.237 0 N-CA-C 115.057 1.137 . . . . 0.0 115.057 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 3' ' ' PRO . 3.2 Cg_exo -53.38 133.54 53.49 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.302 1.334 . . . . 0.0 112.883 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 5' ' ' THR . 2.3 t -126.34 86.19 58.65 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.421 ' HG3' ' CD1' ' A' ' 19' ' ' PHE . 3.0 Cg_endo -55.98 151.6 40.93 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 121.78 1.653 . . . . 0.0 112.201 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -65.68 -62.36 0.08 OUTLIER 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 121.917 1.745 . . . . 0.0 111.884 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.45 175.57 44.8 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -66.5 -34.93 79.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -1.097 . . . . 0.0 109.794 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.8 mp0 -63.65 -26.91 68.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.37 -0.831 . . . . 0.0 110.35 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.412 ' HB1' ' OD2' ' A' ' 15' ' ' ASP . . . -57.95 146.5 67.91 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.06 -1.025 . . . . 0.0 109.966 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -50.49 150.6 11.38 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.652 2.235 . . . . 0.0 112.079 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.7 p -58.83 -21.16 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 0.0 110.21 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.95 -37.06 86.02 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.0 -1.063 . . . . 0.0 108.637 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.412 ' OD2' ' HB1' ' A' ' 11' ' ' ALA . 89.7 m-20 -64.26 -39.81 94.71 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.1 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.2 tp -63.28 -39.98 96.09 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.348 -0.845 . . . . 0.0 109.513 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 84.2 mt -57.88 -48.89 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.22 -0.925 . . . . 0.0 109.482 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.586 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 1.3 ttm105 -55.63 -38.96 70.19 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.207 -0.933 . . . . 0.0 109.007 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.421 ' CD1' ' HG3' ' A' ' 6' ' ' PRO . 86.8 t80 -59.44 -45.46 91.51 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.176 -0.952 . . . . 0.0 109.109 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -62.69 -41.34 99.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.408 -0.808 . . . . 0.0 110.077 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.789 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 26.0 p30 -63.9 -33.84 76.6 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.109 -0.994 . . . . 0.0 109.997 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.789 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 78.2 m-20 -67.39 -42.72 82.87 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.909 -1.119 . . . . 0.0 108.494 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.6 tp -62.69 -38.22 89.57 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -58.35 -40.29 81.79 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.434 ' O ' HG22 ' A' ' 29' ' ' VAL . 50.9 tt0 -62.56 -38.36 89.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.317 -0.864 . . . . 0.0 108.976 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -55.45 -51.25 67.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.471 -0.768 . . . . 0.0 109.604 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.606 ' O ' HG23 ' A' ' 30' ' ' VAL . 79.3 mt -67.27 -36.21 81.11 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.544 -0.723 . . . . 0.0 109.369 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -61.09 -44.13 97.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.499 -0.751 . . . . 0.0 110.472 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.579 ' O ' ' OXT' ' A' ' 30' ' ' VAL . 35.5 m -76.35 -30.58 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.078 -1.014 . . . . 0.0 109.887 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 27' ' ' LEU . 43.6 t . . . . . 0 C--N 1.302 -1.489 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.584 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.531 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 3.8 Cg_exo . . . . . 0 N--CA 1.488 1.186 0 N-CA-C 114.181 0.801 . . . . 0.0 114.181 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 3' ' ' PRO . 3.0 Cg_exo -62.62 144.42 94.22 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.034 1.823 . . . . 0.0 112.559 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.62 125.57 36.94 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.317 -0.865 . . . . 0.0 108.913 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -56.51 151.05 48.06 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.809 1.672 . . . . 0.0 112.494 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -69.05 174.62 8.63 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.144 1.896 . . . . 0.0 111.86 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.21 172.88 54.84 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 55.6 mp0 -67.09 -44.96 78.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.992 -1.299 . . . . 0.0 110.012 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -83.71 -2.97 57.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.208 -0.933 . . . . 0.0 109.549 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.34 143.16 93.19 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 109.776 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -52.36 149.26 23.44 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.569 2.179 . . . . 0.0 112.276 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 m -65.55 -23.5 32.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.437 -0.79 . . . . 0.0 109.265 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -61.71 -36.3 80.54 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -61.05 -39.84 91.36 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.704 -0.798 . . . . 0.0 109.024 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.7 tt -61.15 -39.85 91.62 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.0 mt -63.25 -42.83 97.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.406 ' HG3' ' OD1' ' A' ' 21' ' ' ASN . 8.9 ttm180 -57.57 -38.55 74.99 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.47 ' CE2' ' HB2' ' A' ' 4' ' ' PRO . 37.6 t80 -58.78 -41.57 86.96 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.37 -0.831 . . . . 0.0 108.795 178.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -58.77 -44.41 90.62 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.447 -0.783 . . . . 0.0 109.759 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.791 ' ND2' ' N ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -64.41 -38.55 91.42 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.044 -1.035 . . . . 0.0 109.397 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.791 ' N ' ' ND2' ' A' ' 21' ' ' ASN . 48.6 t0 -64.33 -29.78 70.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.139 -0.976 . . . . 0.0 109.117 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.7 tt -68.83 -38.71 80.01 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.081 -1.012 . . . . 0.0 108.593 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -59.14 -45.94 89.65 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.799 ' O ' HG22 ' A' ' 29' ' ' VAL . 44.9 tt0 -63.55 -34.18 77.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.944 . . . . 0.0 108.749 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.606 ' CD1' ' C ' ' A' ' 26' ' ' TYR . 0.6 OUTLIER -64.4 -54.17 36.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.581 -0.699 . . . . 0.0 110.494 -179.572 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.433 ' HA ' HD23 ' A' ' 27' ' ' LEU . 93.8 mt -78.29 -37.01 45.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -0.992 . . . . 0.0 110.577 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -60.51 -42.31 96.13 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.149 -0.97 . . . . 0.0 111.03 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.799 HG22 ' O ' ' A' ' 25' ' ' GLN . 35.2 m -71.08 -29.93 38.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 30' ' ' VAL . 57.3 t . . . . . 0 C--N 1.303 -1.434 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.837 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.535 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 3.7 Cg_exo . . . . . 0 N--CA 1.489 1.211 0 N-CA-C 113.915 0.698 . . . . 0.0 113.915 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 3' ' ' PRO . 3.5 Cg_exo -63.04 127.84 21.37 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 121.908 1.739 . . . . 0.0 112.109 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.575 ' O ' ' CE2' ' A' ' 19' ' ' PHE . 30.0 m -118.12 109.58 40.7 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -56.16 149.76 52.29 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.333 1.355 . . . . 0.0 112.908 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.428 ' CG ' ' OD1' ' A' ' 15' ' ' ASP . 2.4 Cg_endo -65.51 164.91 24.43 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.624 2.216 . . . . 0.0 112.008 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.3 174.16 55.24 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -66.27 -37.59 85.83 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.015 -1.285 . . . . 0.0 110.173 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.79 -31.83 71.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.299 -0.876 . . . . 0.0 110.42 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.588 ' HB1' ' OD2' ' A' ' 15' ' ' ASP . . . -63.34 147.91 94.27 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.917 . . . . 0.0 110.255 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.614 ' O ' ' OD1' ' A' ' 15' ' ' ASP . 2.9 Cg_endo -50.55 144.95 23.66 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.855 2.37 . . . . 0.0 112.271 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.7 p -65.8 -20.62 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.442 -0.786 . . . . 0.0 110.451 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.533 ' HA ' HD12 ' A' ' 17' ' ' ILE . 57.8 mp0 -63.23 -39.26 94.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.886 -1.134 . . . . 0.0 109.439 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.733 ' OD1' ' N ' ' A' ' 16' ' ' LEU . 46.8 p30 -63.72 -36.72 84.8 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.127 -0.983 . . . . 0.0 109.202 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.733 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 1.1 tp -64.48 -39.16 93.27 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.279 -0.888 . . . . 0.0 109.251 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.533 HD12 ' HA ' ' A' ' 14' ' ' GLU . 97.0 mt -57.43 -50.81 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.452 -0.78 . . . . 0.0 110.023 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.588 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 0.2 OUTLIER -60.63 -41.4 94.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.018 -1.051 . . . . 0.0 110.128 -179.568 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.598 ' O ' HD23 ' A' ' 23' ' ' LEU . 7.0 m-85 -67.79 -36.51 80.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.87 -1.144 . . . . 0.0 109.189 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -57.01 -39.46 74.78 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.809 ' ND2' ' N ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -66.7 -43.13 85.2 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.109 179.454 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.809 ' N ' ' ND2' ' A' ' 21' ' ' ASN . 93.9 m-20 -60.34 -37.26 80.07 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.598 HD23 ' O ' ' A' ' 19' ' ' PHE . 4.0 mm? -64.74 -36.38 84.1 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -53.67 -42.22 67.67 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.854 ' O ' HG23 ' A' ' 29' ' ' VAL . 97.5 mt-30 -67.79 -38.32 83.2 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.428 ' HB3' ' O ' ' A' ' 23' ' ' LEU . 88.7 t80 -55.85 -48.24 75.85 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.609 -0.682 . . . . 0.0 109.983 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 30' ' ' VAL . 36.4 mt -62.76 -49.98 72.85 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.483 -0.76 . . . . 0.0 110.283 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -69.13 -36.2 77.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.831 -1.168 . . . . 0.0 108.359 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 25' ' ' GLN . 62.4 t -65.78 -37.8 80.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.492 ' O ' ' O ' ' A' ' 29' ' ' VAL . 74.0 t . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.359 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo . . . . . 0 N--CA 1.489 1.231 0 CA-C-O 120.667 0.195 . . . . 0.0 112.216 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -59.7 150.28 77.77 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.139 1.893 . . . . 0.0 111.625 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 m -123.46 79.28 54.35 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.134 -0.979 . . . . 0.0 109.352 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.491 ' HG3' ' CE1' ' A' ' 19' ' ' PHE . 2.4 Cg_endo -57.44 152.39 47.4 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.028 1.818 . . . . 0.0 112.362 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.557 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 2.6 Cg_endo -73.28 -147.41 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.184 0 C-N-CA 121.816 1.677 . . . . 0.0 111.378 178.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -83.93 175.23 51.67 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -66.84 -37.67 84.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.111 -1.229 . . . . 0.0 110.089 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.486 ' O ' ' C ' ' A' ' 11' ' ' ALA . 96.9 mt-10 -67.6 -26.98 66.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.319 -0.863 . . . . 0.0 110.519 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.557 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . . . -36.88 150.61 0.13 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.069 -1.019 . . . . 0.0 110.075 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -50.26 149.15 12.88 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.926 2.417 . . . . 0.0 111.934 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 m -65.47 -19.64 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.157 -0.964 . . . . 0.0 109.459 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.16 -38.14 89.99 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -65.83 -38.77 89.81 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.159 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.3 tp -60.99 -42.73 98.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.319 -0.863 . . . . 0.0 109.329 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 72.5 mt -59.8 -49.23 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.41 -0.806 . . . . 0.0 109.433 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.728 ' HE ' ' N ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -55.68 -35.45 66.03 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.442 -0.786 . . . . 0.0 109.036 179.695 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.728 ' N ' ' HE ' ' A' ' 18' ' ' ARG . 93.9 t80 -61.67 -52.03 66.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.214 -0.928 . . . . 0.0 108.935 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -58.74 -39.44 80.9 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -60.86 -45.12 95.81 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -69.44 -39.32 77.89 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.565 -0.71 . . . . 0.0 109.715 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.2 tp -58.37 -43.18 88.32 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.242 -0.912 . . . . 0.0 108.934 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.455 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 53.5 tt0 -61.09 -39.72 91.0 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.873 ' O ' HG22 ' A' ' 29' ' ' VAL . 47.4 tt0 -59.85 -40.0 87.08 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.502 -0.749 . . . . 0.0 109.202 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -66.47 -51.22 59.14 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.341 -0.849 . . . . 0.0 110.434 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.548 ' O ' HG23 ' A' ' 30' ' ' VAL . 60.8 mt -74.85 -38.97 61.84 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 110.245 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 24' ' ' GLN . 27.9 t30 -60.28 -43.06 96.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.334 -0.854 . . . . 0.0 110.885 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.873 HG22 ' O ' ' A' ' 25' ' ' GLN . 25.2 m -72.41 -30.58 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 120.913 -1.117 . . . . 0.0 108.727 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 27' ' ' LEU . 78.1 t . . . . . 0 C--N 1.304 -1.411 0 CA-C-O 118.066 -0.968 . . . . 0.0 109.812 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.509 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 3.5 Cg_exo . . . . . 0 N--CA 1.491 1.329 0 N-CA-C 114.118 0.776 . . . . 0.0 114.118 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.509 ' CD ' ' N ' ' A' ' 3' ' ' PRO . 3.9 Cg_exo -62.65 130.98 31.53 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.967 1.778 . . . . 0.0 112.458 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 5' ' ' THR . 3.3 t -126.27 86.88 57.27 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 109.072 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.454 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 3.0 Cg_exo -55.67 151.58 38.55 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.585 1.523 . . . . 0.0 112.138 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.551 ' CD ' ' OD1' ' A' ' 15' ' ' ASP . 2.8 Cg_endo -58.89 -69.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.589 2.192 . . . . 0.0 111.984 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.89 175.7 40.94 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.14 -33.64 75.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.382 -1.069 . . . . 0.0 110.082 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -58.66 -32.62 69.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -0.931 . . . . 0.0 109.736 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.88 149.49 92.63 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.245 -0.909 . . . . 0.0 109.851 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -50.0 146.55 16.76 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.741 2.294 . . . . 0.0 111.99 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.11 -18.3 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.325 -0.859 . . . . 0.0 110.205 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.79 -36.21 82.39 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 120.974 -1.078 . . . . 0.0 109.16 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.551 ' OD1' ' CD ' ' A' ' 7' ' ' PRO . 13.3 t70 -61.94 -41.54 98.09 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.573 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 45.0 mt -65.58 -36.63 84.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.001 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.7 mt -59.43 -49.62 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.072 -1.018 . . . . 0.0 110.146 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.508 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 22.9 mtp180 -62.58 -42.03 99.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.651 -1.281 . . . . 0.0 109.471 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.454 ' CE2' ' HA ' ' A' ' 6' ' ' PRO . 6.9 m-85 -61.18 -34.64 75.38 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -58.01 -38.15 75.62 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -59.35 -45.96 89.96 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.028 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -61.79 -37.49 84.56 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.428 HD23 ' HD2' ' A' ' 26' ' ' TYR . 5.9 mt -62.73 -36.74 83.98 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.498 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 63.5 tt0 -58.93 -47.67 84.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.354 -0.842 . . . . 0.0 108.926 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.925 ' O ' HG22 ' A' ' 29' ' ' VAL . 61.1 tt0 -63.7 -41.35 98.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.169 -0.957 . . . . 0.0 108.92 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.618 ' CD1' ' C ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -66.03 -51.68 56.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.609 -0.682 . . . . 0.0 110.071 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.537 ' O ' HG23 ' A' ' 30' ' ' VAL . 89.4 mt -74.08 -38.47 63.89 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.918 -1.114 . . . . 0.0 110.325 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 24' ' ' GLN . 25.3 t30 -62.83 -42.58 99.79 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.991 -1.068 . . . . 0.0 110.56 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.925 HG22 ' O ' ' A' ' 25' ' ' GLN . 31.3 m -76.85 -31.09 18.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 120.92 -1.113 . . . . 0.0 108.778 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 27' ' ' LEU . 76.9 t . . . . . 0 C--N 1.304 -1.394 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.696 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.523 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 4.1 Cg_exo . . . . . 0 N--CA 1.488 1.193 0 N-CA-C 114.079 0.761 . . . . 0.0 114.079 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' A' ' 3' ' ' PRO . 3.2 Cg_exo -64.41 140.75 71.3 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.324 2.016 . . . . 0.0 112.514 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.64 144.21 30.95 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.298 -0.876 . . . . 0.0 108.919 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 2.5 Cg_endo -56.0 151.07 43.74 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.104 1.869 . . . . 0.0 111.986 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 2.4 Cg_endo -79.03 168.02 21.17 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.199 1.933 . . . . 0.0 111.885 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.37 155.89 53.18 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -60.88 -38.93 87.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.885 -1.362 . . . . 0.0 109.346 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -71.73 -24.75 61.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.466 -0.772 . . . . 0.0 109.993 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.76 142.42 16.43 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.131 -0.981 . . . . 0.0 110.022 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -52.71 148.34 28.43 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.605 2.204 . . . . 0.0 112.073 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.02 -23.17 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.296 -0.877 . . . . 0.0 109.734 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.67 -33.5 75.76 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 120.954 -1.092 . . . . 0.0 108.435 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -61.3 -40.34 93.8 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.468 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.6 mp -62.19 -41.3 98.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.131 -0.981 . . . . 0.0 108.735 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.2 mt -58.97 -44.25 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.427 -0.909 . . . . 0.0 108.684 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.476 ' HG3' ' ND2' ' A' ' 21' ' ' ASN . 18.9 ttm180 -61.69 -38.62 88.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.391 -0.818 . . . . 0.0 109.446 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -55.74 -46.36 77.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.261 -0.899 . . . . 0.0 108.889 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -61.68 -39.19 90.55 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.569 ' ND2' ' OD1' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -60.0 -44.46 94.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.408 -0.808 . . . . 0.0 109.344 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.569 ' OD1' ' ND2' ' A' ' 21' ' ' ASN . 89.9 m-20 -59.51 -40.74 88.09 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.285 -0.885 . . . . 0.0 109.718 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 38.0 tp -60.07 -41.07 91.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.023 -1.048 . . . . 0.0 108.959 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.446 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 46.1 tt0 -60.81 -38.46 85.46 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.84 ' O ' HG22 ' A' ' 29' ' ' VAL . 61.8 tp60 -60.58 -40.21 90.91 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.393 -0.817 . . . . 0.0 108.953 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.442 ' CD1' ' C ' ' A' ' 26' ' ' TYR . 25.2 t80 -69.02 -52.54 27.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.348 -0.845 . . . . 0.0 110.079 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.48 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 78.2 mt -70.16 -37.53 75.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.358 -0.839 . . . . 0.0 110.237 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 24' ' ' GLN . 29.1 t30 -68.29 -41.29 81.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.117 -0.989 . . . . 0.0 110.83 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.84 HG22 ' O ' ' A' ' 25' ' ' GLN . 17.3 m -78.99 -35.19 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 120.974 -1.079 . . . . 0.0 109.49 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.48 ' CG2' ' O ' ' A' ' 27' ' ' LEU . 25.1 t . . . . . 0 C--N 1.302 -1.472 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.607 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.508 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 3.5 Cg_exo . . . . . 0 N--CA 1.49 1.293 0 N-CA-C 114.018 0.738 . . . . 0.0 114.018 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 3' ' ' PRO . 3.5 Cg_exo -59.7 140.89 95.68 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.693 1.595 . . . . 0.0 112.367 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.34 160.98 39.39 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -55.55 150.9 40.79 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 121.628 1.552 . . . . 0.0 111.799 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -79.29 -67.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.921 1.747 . . . . 0.0 112.296 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 145.26 148.12 4.76 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -57.88 -44.55 86.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.036 -1.273 . . . . 0.0 109.979 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -71.9 -29.14 64.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.912 . . . . 0.0 109.558 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -46.93 124.83 8.26 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.278 -0.889 . . . . 0.0 109.992 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.86 155.89 52.02 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 121.971 1.781 . . . . 0.0 111.688 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.9 p -56.01 -19.26 6.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.223 -0.923 . . . . 0.0 109.881 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -64.89 -41.93 95.2 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.987 -1.07 . . . . 0.0 108.545 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -67.03 -40.97 87.34 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.719 -0.792 . . . . 0.0 109.095 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.4 -38.53 87.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.391 -0.818 . . . . 0.0 109.091 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 54.2 mt -57.65 -53.83 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.423 -0.798 . . . . 0.0 110.209 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.73 ' HE ' ' C ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -55.59 -39.55 70.87 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.097 -1.002 . . . . 0.0 108.52 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.595 ' N ' ' HE ' ' A' ' 18' ' ' ARG . 13.3 t80 -62.42 -42.96 99.84 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.443 -0.786 . . . . 0.0 109.191 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -58.4 -43.49 88.58 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.481 -0.762 . . . . 0.0 109.541 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.766 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 28.1 p30 -69.06 -32.87 72.65 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.142 -0.974 . . . . 0.0 109.967 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.766 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 88.0 m-20 -63.55 -44.35 94.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.156 -0.965 . . . . 0.0 109.618 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.7 tp -65.87 -40.21 91.41 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.319 -0.863 . . . . 0.0 109.493 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.445 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 36.0 tt0 -60.39 -47.61 85.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 109.21 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.787 ' O ' HG22 ' A' ' 29' ' ' VAL . 97.3 mt-30 -66.01 -33.47 75.88 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.21 -0.931 . . . . 0.0 108.844 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.566 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.8 OUTLIER -64.37 -55.75 19.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.465 -0.772 . . . . 0.0 110.363 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.561 ' O ' HG23 ' A' ' 30' ' ' VAL . 96.2 mt -76.93 -38.81 52.67 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.093 -1.004 . . . . 0.0 110.381 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.445 ' CB ' ' O ' ' A' ' 24' ' ' GLN . 17.9 t30 -61.72 -43.12 99.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.152 -0.968 . . . . 0.0 110.74 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 25' ' ' GLN . 15.7 m -71.76 -30.8 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 120.921 -1.112 . . . . 0.0 108.82 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.575 ' O ' ' O ' ' A' ' 29' ' ' VAL . 71.4 t . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.586 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.48 0.734 0 N-CA-C 109.539 -0.985 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.747 ' O ' ' CG ' ' A' ' 2' ' ' PHE . 1.8 p90 -122.66 94.75 47.3 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.122 -0.986 . . . . 0.0 109.547 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.451 ' CG ' ' HD3' ' A' ' 4' ' ' PRO . 5.0 Cg_exo -61.01 -47.38 12.82 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 C-N-CA 122.444 2.096 . . . . 0.0 113.736 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.451 ' HD3' ' CG ' ' A' ' 3' ' ' PRO . 3.1 Cg_exo -69.92 132.98 24.19 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.174 1.916 . . . . 0.0 112.444 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.7 m -110.25 125.22 31.44 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.462 ' HA ' ' CD1' ' A' ' 19' ' ' PHE . 3.0 Cg_exo -54.07 150.79 30.16 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.411 1.407 . . . . 0.0 112.024 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -80.61 163.76 21.27 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 C-N-CA 122.448 2.099 . . . . 0.0 112.241 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.69 172.72 52.2 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -64.55 -36.39 84.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.038 -1.272 . . . . 0.0 109.57 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.92 -28.9 68.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.406 -0.809 . . . . 0.0 110.153 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.39 141.14 71.59 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.174 -0.954 . . . . 0.0 110.002 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -54.35 149.44 37.61 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.541 2.161 . . . . 0.0 112.258 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.9 p -60.71 -22.49 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.327 -0.858 . . . . 0.0 109.743 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.87 -34.39 77.28 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -61.42 -38.08 85.81 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.57 ' O ' HD13 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -61.9 -42.23 98.84 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.329 -0.857 . . . . 0.0 108.795 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.3 mt -60.3 -46.52 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.124 -0.985 . . . . 0.0 108.812 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.454 ' NH1' ' HG2' ' A' ' 18' ' ' ARG . 8.5 tpp85 -61.52 -40.18 93.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -0.858 . . . . 0.0 109.444 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.462 ' CD1' ' HA ' ' A' ' 6' ' ' PRO . 62.8 t80 -57.18 -45.71 83.44 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.214 -0.928 . . . . 0.0 108.499 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -59.72 -40.08 86.82 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -61.11 -47.3 86.93 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.586 0.708 . . . . 0.0 109.203 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -66.73 -39.75 88.1 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.249 -0.907 . . . . 0.0 109.346 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 32.8 tp -60.2 -40.03 88.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.243 -0.911 . . . . 0.0 108.892 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -59.06 -39.98 83.72 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.855 ' O ' HG23 ' A' ' 29' ' ' VAL . 99.5 mm-40 -60.93 -38.74 86.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.395 -0.816 . . . . 0.0 108.918 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 76.4 t80 -55.45 -49.6 72.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.396 -0.815 . . . . 0.0 110.089 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.764 ' O ' HG23 ' A' ' 30' ' ' VAL . 64.9 mt -60.62 -48.9 79.74 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.313 -0.867 . . . . 0.0 109.934 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.716 ' H ' HD22 ' A' ' 28' ' ' ASN . 0.7 OUTLIER -67.4 -37.02 82.46 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.888 -1.133 . . . . 0.0 108.155 178.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 25' ' ' GLN . 71.4 t -67.97 -39.04 80.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 121.426 0.631 . . . . 0.0 109.445 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 27' ' ' LEU . 72.7 t . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.005 -0.997 . . . . 0.0 109.518 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.481 0.749 0 N-CA-C 109.739 -0.908 . . . . 0.0 109.739 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.671 ' O ' ' CG ' ' A' ' 2' ' ' PHE . 2.5 p90 -58.76 112.21 4.7 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.188 -0.945 . . . . 0.0 109.547 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.538 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 3.7 Cg_exo -60.58 -42.36 40.61 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.497 2.131 . . . . 0.0 113.82 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.619 ' O ' ' CE2' ' A' ' 2' ' ' PHE . 3.2 Cg_exo -64.21 139.21 65.11 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.228 1.952 . . . . 0.0 112.845 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.4 m -123.69 129.33 24.87 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.373 -0.829 . . . . 0.0 108.777 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -55.5 151.83 36.1 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 121.797 1.665 . . . . 0.0 112.471 -178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -76.51 166.14 27.87 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.333 2.022 . . . . 0.0 111.969 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.57 174.64 50.38 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -65.32 -36.58 84.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.102 -1.234 . . . . 0.0 109.843 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.3 mp0 -66.56 -31.47 72.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.333 -0.854 . . . . 0.0 110.03 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.81 139.64 77.0 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.056 -1.027 . . . . 0.0 109.549 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -53.74 152.57 21.89 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.254 1.97 . . . . 0.0 111.884 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.0 m -64.36 -29.34 47.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.242 -0.911 . . . . 0.0 109.247 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -60.61 -36.04 77.63 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -59.58 -39.67 84.89 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.8 tt -60.54 -40.46 91.63 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.404 -0.81 . . . . 0.0 109.007 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.2 mt -58.34 -48.32 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.199 -0.938 . . . . 0.0 109.502 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.642 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 54.0 mtp180 -60.05 -38.01 81.53 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.15 -0.969 . . . . 0.0 109.19 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -54.88 -42.23 71.83 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -60.22 -38.67 84.08 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.642 ' ND2' ' O ' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -58.63 -47.85 83.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.371 -0.831 . . . . 0.0 109.647 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.591 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 93.0 m-20 -59.66 -38.53 81.71 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.117 -0.989 . . . . 0.0 108.887 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.6 tp -59.34 -38.42 80.33 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -59.16 -44.27 92.11 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.365 -0.834 . . . . 0.0 108.942 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.605 ' O ' HG22 ' A' ' 29' ' ' VAL . 58.2 tt0 -65.11 -37.0 86.07 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.385 -0.822 . . . . 0.0 109.398 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -57.21 -47.22 81.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.563 -0.71 . . . . 0.0 110.641 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.584 ' O ' HG23 ' A' ' 30' ' ' VAL . 76.3 mt -69.24 -39.85 78.26 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.198 -0.938 . . . . 0.0 110.114 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.752 HD22 ' N ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -63.99 -42.38 97.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.139 -0.976 . . . . 0.0 110.244 -179.529 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 25' ' ' GLN . 21.6 m -79.31 -30.56 14.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 O-C-N 121.177 -0.952 . . . . 0.0 109.932 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 27' ' ' LEU . 41.1 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.424 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo . . . . . 0 N--CA 1.481 0.789 0 N-CA-C 109.721 -0.915 . . . . 0.0 109.721 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -53.57 153.77 7.33 Favored Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.314 -0.866 . . . . 0.0 109.856 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -72.61 144.86 40.69 Favored 'Trans proline' 0 C--N 1.32 -0.953 0 C-N-CA 121.448 1.432 . . . . 0.0 112.09 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -52.75 147.13 32.66 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.614 2.21 . . . . 0.0 112.129 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.573 HG23 ' O ' ' A' ' 5' ' ' THR . 3.0 t -125.41 79.59 66.63 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.255 -0.903 . . . . 0.0 108.985 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.489 ' HG3' ' CD1' ' A' ' 19' ' ' PHE . 2.7 Cg_endo -55.96 156.39 19.93 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.126 1.884 . . . . 0.0 111.98 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -69.31 -62.99 0.05 OUTLIER 'Trans proline' 0 N--CA 1.489 1.224 0 C-N-CA 121.784 1.656 . . . . 0.0 111.79 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 167.91 173.29 35.8 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -62.67 -31.35 72.22 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -1.185 . . . . 0.0 109.974 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -60.21 -31.02 69.77 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.353 -0.842 . . . . 0.0 109.635 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.991 ' HB1' ' OD2' ' A' ' 15' ' ' ASP . . . -66.89 147.57 99.04 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.102 -0.999 . . . . 0.0 109.489 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -49.65 147.87 12.75 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.532 2.155 . . . . 0.0 112.079 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.02 -18.83 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.317 -0.864 . . . . 0.0 109.568 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.18 -34.84 75.7 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.991 ' OD2' ' HB1' ' A' ' 11' ' ' ALA . 90.1 m-20 -62.22 -39.34 92.45 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 37.1 tp -58.38 -41.12 84.12 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 38.8 mt -55.79 -49.97 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.365 -0.834 . . . . 0.0 109.486 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.746 ' HE ' ' C ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -54.36 -42.52 70.39 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.772 -1.205 . . . . 0.0 108.231 -179.542 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.55 ' N ' ' HE ' ' A' ' 18' ' ' ARG . 67.7 t80 -60.67 -37.47 81.68 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.399 -0.813 . . . . 0.0 108.924 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.765 ' CD1' ' N ' ' A' ' 21' ' ' ASN . 0.0 OUTLIER -56.27 -53.88 51.94 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.551 -0.718 . . . . 0.0 109.429 -179.448 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.765 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 1.7 p30 -66.12 -37.64 86.22 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.424 -0.798 . . . . 0.0 110.154 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.587 ' OD2' ' NE ' ' A' ' 18' ' ' ARG . 89.5 m-20 -62.48 -43.93 97.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.945 -1.097 . . . . 0.0 109.716 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.9 tp -66.12 -38.68 88.78 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.271 -0.893 . . . . 0.0 109.562 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -58.8 -46.05 88.48 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 109.472 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.42 ' O ' HG22 ' A' ' 29' ' ' VAL . 50.1 tt0 -64.25 -37.79 88.72 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.193 -0.942 . . . . 0.0 109.206 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -55.8 -44.32 77.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.522 -0.737 . . . . 0.0 110.261 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.573 ' O ' HG23 ' A' ' 30' ' ' VAL . 38.9 mt -68.45 -40.9 80.92 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.418 -0.801 . . . . 0.0 110.129 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.673 HD22 ' N ' ' A' ' 28' ' ' ASN . 0.8 OUTLIER -63.7 -39.8 95.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.245 -0.91 . . . . 0.0 110.289 -179.598 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.554 ' O ' ' O ' ' A' ' 30' ' ' VAL . 32.8 m -77.03 -30.8 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 120.998 -1.063 . . . . 0.0 109.402 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 27' ' ' LEU . 69.0 t . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.554 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo . . . . . 0 N--CA 1.481 0.79 0 N-CA-C 109.862 -0.861 . . . . 0.0 109.862 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.691 ' O ' ' CG ' ' A' ' 2' ' ' PHE . 2.8 p90 -56.59 111.87 3.8 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.21 -0.931 . . . . 0.0 109.614 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.58 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 3.2 Cg_exo -64.59 -36.12 44.22 Favored 'Trans proline' 0 CA--C 1.549 1.237 0 C-N-CA 122.581 2.187 . . . . 0.0 115.057 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 3' ' ' PRO . 3.2 Cg_exo -53.38 133.54 53.49 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 C-N-CA 121.302 1.334 . . . . 0.0 112.883 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.571 HG23 ' O ' ' A' ' 5' ' ' THR . 2.3 t -126.34 86.19 58.65 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.421 ' HG3' ' CD1' ' A' ' 19' ' ' PHE . 3.0 Cg_endo -55.98 151.6 40.93 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 121.78 1.653 . . . . 0.0 112.201 -178.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -65.68 -62.36 0.08 OUTLIER 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 121.917 1.745 . . . . 0.0 111.884 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.45 175.57 44.8 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -66.5 -34.93 79.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -1.097 . . . . 0.0 109.794 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 53.8 mp0 -63.65 -26.91 68.89 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.37 -0.831 . . . . 0.0 110.35 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.412 ' HB1' ' OD2' ' A' ' 15' ' ' ASP . . . -57.95 146.5 67.91 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.06 -1.025 . . . . 0.0 109.966 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -50.49 150.6 11.38 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.652 2.235 . . . . 0.0 112.079 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.7 p -58.83 -21.16 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -0.919 . . . . 0.0 110.21 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.95 -37.06 86.02 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.0 -1.063 . . . . 0.0 108.637 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.412 ' OD2' ' HB1' ' A' ' 11' ' ' ALA . 89.7 m-20 -64.26 -39.81 94.71 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.1 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.2 tp -63.28 -39.98 96.09 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.348 -0.845 . . . . 0.0 109.513 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 84.2 mt -57.88 -48.89 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.22 -0.925 . . . . 0.0 109.482 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.586 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 1.3 ttm105 -55.63 -38.96 70.19 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.207 -0.933 . . . . 0.0 109.007 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.421 ' CD1' ' HG3' ' A' ' 6' ' ' PRO . 86.8 t80 -59.44 -45.46 91.51 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.176 -0.952 . . . . 0.0 109.109 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -62.69 -41.34 99.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.408 -0.808 . . . . 0.0 110.077 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.789 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 26.0 p30 -63.9 -33.84 76.6 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.109 -0.994 . . . . 0.0 109.997 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.789 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 78.2 m-20 -67.39 -42.72 82.87 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 120.909 -1.119 . . . . 0.0 108.494 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.6 tp -62.69 -38.22 89.57 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -58.35 -40.29 81.79 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.434 ' O ' HG22 ' A' ' 29' ' ' VAL . 50.9 tt0 -62.56 -38.36 89.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.317 -0.864 . . . . 0.0 108.976 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -55.45 -51.25 67.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.471 -0.768 . . . . 0.0 109.604 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.606 ' O ' HG23 ' A' ' 30' ' ' VAL . 79.3 mt -67.27 -36.21 81.11 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.544 -0.723 . . . . 0.0 109.369 179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -61.09 -44.13 97.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.499 -0.751 . . . . 0.0 110.472 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.579 ' O ' ' OXT' ' A' ' 30' ' ' VAL . 35.5 m -76.35 -30.58 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.078 -1.014 . . . . 0.0 109.887 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 27' ' ' LEU . 43.6 t . . . . . 0 C--N 1.302 -1.489 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.584 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . 0.711 ' O ' ' CE2' ' A' ' 26' ' ' TYR . 3.1 Cg_exo . . . . . 0 C--O 1.213 -0.751 0 N-CA-C 109.732 -0.911 . . . . 0.0 109.732 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.731 ' CG ' ' O ' ' A' ' 2' ' ' PHE . 21.4 p90 -131.24 98.12 19.05 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.259 -0.901 . . . . 0.0 109.357 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.531 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 3.8 Cg_exo -61.0 -42.47 36.56 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 C-N-CA 122.41 2.073 . . . . 0.0 114.181 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 3' ' ' PRO . 3.0 Cg_exo -62.62 144.42 94.22 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.034 1.823 . . . . 0.0 112.559 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.62 125.57 36.94 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.317 -0.865 . . . . 0.0 108.913 179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -56.51 151.05 48.06 Favored 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 121.809 1.672 . . . . 0.0 112.494 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -69.05 174.62 8.63 Favored 'Trans proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.144 1.896 . . . . 0.0 111.86 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -80.21 172.88 54.84 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 55.6 mp0 -67.09 -44.96 78.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.992 -1.299 . . . . 0.0 110.012 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -83.71 -2.97 57.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.208 -0.933 . . . . 0.0 109.549 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.34 143.16 93.19 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.0 109.776 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -52.36 149.26 23.44 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.569 2.179 . . . . 0.0 112.276 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 m -65.55 -23.5 32.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.437 -0.79 . . . . 0.0 109.265 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -61.71 -36.3 80.54 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -61.05 -39.84 91.36 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.704 -0.798 . . . . 0.0 109.024 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 7.7 tt -61.15 -39.85 91.62 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.0 mt -63.25 -42.83 97.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.406 ' HG3' ' OD1' ' A' ' 21' ' ' ASN . 8.9 ttm180 -57.57 -38.55 74.99 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.47 ' CE2' ' HB2' ' A' ' 4' ' ' PRO . 37.6 t80 -58.78 -41.57 86.96 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.37 -0.831 . . . . 0.0 108.795 178.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -58.77 -44.41 90.62 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.447 -0.783 . . . . 0.0 109.759 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.791 ' ND2' ' N ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -64.41 -38.55 91.42 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.044 -1.035 . . . . 0.0 109.397 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.791 ' N ' ' ND2' ' A' ' 21' ' ' ASN . 48.6 t0 -64.33 -29.78 70.85 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.139 -0.976 . . . . 0.0 109.117 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.7 tt -68.83 -38.71 80.01 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.081 -1.012 . . . . 0.0 108.593 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -59.14 -45.94 89.65 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.799 ' O ' HG22 ' A' ' 29' ' ' VAL . 44.9 tt0 -63.55 -34.18 77.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.189 -0.944 . . . . 0.0 108.749 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.711 ' CE2' ' O ' ' A' ' 1' ' ' PRO . 0.6 OUTLIER -64.4 -54.17 36.93 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.581 -0.699 . . . . 0.0 110.494 -179.572 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.433 ' HA ' HD23 ' A' ' 27' ' ' LEU . 93.8 mt -78.29 -37.01 45.91 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.113 -0.992 . . . . 0.0 110.577 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -60.51 -42.31 96.13 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.149 -0.97 . . . . 0.0 111.03 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.799 HG22 ' O ' ' A' ' 25' ' ' GLN . 35.2 m -71.08 -29.93 38.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.43 ' O ' HG12 ' A' ' 30' ' ' VAL . 57.3 t . . . . . 0 C--N 1.303 -1.434 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.837 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo . . . . . 0 N--CA 1.48 0.735 0 N-CA-C 110.0 -0.808 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.687 ' CG ' ' O ' ' A' ' 2' ' ' PHE . 4.6 p90 -115.69 108.15 47.44 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.419 -0.8 . . . . 0.0 109.114 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.535 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 3.7 Cg_exo -60.04 -42.06 47.26 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.425 2.083 . . . . 0.0 113.915 -178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.565 ' O ' ' CE2' ' A' ' 2' ' ' PHE . 3.5 Cg_exo -63.04 127.84 21.37 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 121.908 1.739 . . . . 0.0 112.109 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.575 ' O ' ' CE2' ' A' ' 19' ' ' PHE . 30.0 m -118.12 109.58 40.7 Favored Pre-proline 0 N--CA 1.494 1.748 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -56.16 149.76 52.29 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.333 1.355 . . . . 0.0 112.908 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.428 ' CG ' ' OD1' ' A' ' 15' ' ' ASP . 2.4 Cg_endo -65.51 164.91 24.43 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.624 2.216 . . . . 0.0 112.008 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.3 174.16 55.24 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -66.27 -37.59 85.83 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.015 -1.285 . . . . 0.0 110.173 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.79 -31.83 71.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.299 -0.876 . . . . 0.0 110.42 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.588 ' HB1' ' OD2' ' A' ' 15' ' ' ASP . . . -63.34 147.91 94.27 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.232 -0.917 . . . . 0.0 110.255 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.614 ' O ' ' OD1' ' A' ' 15' ' ' ASP . 2.9 Cg_endo -50.55 144.95 23.66 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.855 2.37 . . . . 0.0 112.271 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.7 p -65.8 -20.62 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.442 -0.786 . . . . 0.0 110.451 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.533 ' HA ' HD12 ' A' ' 17' ' ' ILE . 57.8 mp0 -63.23 -39.26 94.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.886 -1.134 . . . . 0.0 109.439 -179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.733 ' OD1' ' N ' ' A' ' 16' ' ' LEU . 46.8 p30 -63.72 -36.72 84.8 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.127 -0.983 . . . . 0.0 109.202 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.733 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 1.1 tp -64.48 -39.16 93.27 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.279 -0.888 . . . . 0.0 109.251 178.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.533 HD12 ' HA ' ' A' ' 14' ' ' GLU . 97.0 mt -57.43 -50.81 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.452 -0.78 . . . . 0.0 110.023 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.588 ' O ' ' OD1' ' A' ' 21' ' ' ASN . 0.2 OUTLIER -60.63 -41.4 94.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.018 -1.051 . . . . 0.0 110.128 -179.568 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.598 ' O ' HD23 ' A' ' 23' ' ' LEU . 7.0 m-85 -67.79 -36.51 80.57 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.87 -1.144 . . . . 0.0 109.189 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -57.01 -39.46 74.78 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.809 ' ND2' ' N ' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -66.7 -43.13 85.2 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.109 179.454 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.809 ' N ' ' ND2' ' A' ' 21' ' ' ASN . 93.9 m-20 -60.34 -37.26 80.07 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 178.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.598 HD23 ' O ' ' A' ' 19' ' ' PHE . 4.0 mm? -64.74 -36.38 84.1 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -53.67 -42.22 67.67 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.854 ' O ' HG23 ' A' ' 29' ' ' VAL . 97.5 mt-30 -67.79 -38.32 83.2 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.428 ' HB3' ' O ' ' A' ' 23' ' ' LEU . 88.7 t80 -55.85 -48.24 75.85 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.609 -0.682 . . . . 0.0 109.983 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 30' ' ' VAL . 36.4 mt -62.76 -49.98 72.85 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.483 -0.76 . . . . 0.0 110.283 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -69.13 -36.2 77.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.831 -1.168 . . . . 0.0 108.359 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 25' ' ' GLN . 62.4 t -65.78 -37.8 80.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.492 ' O ' ' O ' ' A' ' 29' ' ' VAL . 74.0 t . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.359 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo . . . . . 0 N--CA 1.48 0.714 0 N-CA-C 109.762 -0.899 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -130.99 143.08 47.95 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.116 -0.99 . . . . 0.0 109.373 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.73 132.96 32.28 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 121.863 1.709 . . . . 0.0 112.216 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -59.7 150.28 77.77 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.139 1.893 . . . . 0.0 111.625 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.6 m -123.46 79.28 54.35 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.134 -0.979 . . . . 0.0 109.352 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.491 ' HG3' ' CE1' ' A' ' 19' ' ' PHE . 2.4 Cg_endo -57.44 152.39 47.4 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.028 1.818 . . . . 0.0 112.362 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.557 ' HB2' ' HB2' ' A' ' 11' ' ' ALA . 2.6 Cg_endo -73.28 -147.41 0.03 OUTLIER 'Trans proline' 0 N--CA 1.488 1.184 0 C-N-CA 121.816 1.677 . . . . 0.0 111.378 178.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -83.93 175.23 51.67 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -66.84 -37.67 84.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.111 -1.229 . . . . 0.0 110.089 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.486 ' O ' ' C ' ' A' ' 11' ' ' ALA . 96.9 mt-10 -67.6 -26.98 66.52 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.319 -0.863 . . . . 0.0 110.519 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.557 ' HB2' ' HB2' ' A' ' 7' ' ' PRO . . . -36.88 150.61 0.13 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.069 -1.019 . . . . 0.0 110.075 -179.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -50.26 149.15 12.88 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.926 2.417 . . . . 0.0 111.934 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 m -65.47 -19.64 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.157 -0.964 . . . . 0.0 109.459 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.16 -38.14 89.99 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -65.83 -38.77 89.81 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.159 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 29.3 tp -60.99 -42.73 98.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.319 -0.863 . . . . 0.0 109.329 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 72.5 mt -59.8 -49.23 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.41 -0.806 . . . . 0.0 109.433 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.728 ' HE ' ' N ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -55.68 -35.45 66.03 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.442 -0.786 . . . . 0.0 109.036 179.695 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.728 ' N ' ' HE ' ' A' ' 18' ' ' ARG . 93.9 t80 -61.67 -52.03 66.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.214 -0.928 . . . . 0.0 108.935 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -58.74 -39.44 80.9 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -60.86 -45.12 95.81 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -69.44 -39.32 77.89 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.565 -0.71 . . . . 0.0 109.715 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.2 tp -58.37 -43.18 88.32 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.242 -0.912 . . . . 0.0 108.934 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.455 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 53.5 tt0 -61.09 -39.72 91.0 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.873 ' O ' HG22 ' A' ' 29' ' ' VAL . 47.4 tt0 -59.85 -40.0 87.08 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.502 -0.749 . . . . 0.0 109.202 179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -66.47 -51.22 59.14 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.341 -0.849 . . . . 0.0 110.434 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.548 ' O ' HG23 ' A' ' 30' ' ' VAL . 60.8 mt -74.85 -38.97 61.84 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 110.245 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.455 ' CB ' ' O ' ' A' ' 24' ' ' GLN . 27.9 t30 -60.28 -43.06 96.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.334 -0.854 . . . . 0.0 110.885 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.873 HG22 ' O ' ' A' ' 25' ' ' GLN . 25.2 m -72.41 -30.58 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 120.913 -1.117 . . . . 0.0 108.727 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 27' ' ' LEU . 78.1 t . . . . . 0 C--N 1.304 -1.411 0 CA-C-O 118.066 -0.968 . . . . 0.0 109.812 179.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo . . . . . 0 N--CA 1.48 0.722 0 N-CA-C 109.681 -0.93 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.728 ' O ' ' CG ' ' A' ' 2' ' ' PHE . 11.4 p90 -114.78 101.82 54.58 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.368 -0.833 . . . . 0.0 109.188 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.509 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 3.5 Cg_exo -61.41 -42.67 32.59 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.608 2.205 . . . . 0.0 114.118 -178.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.509 ' CD ' ' N ' ' A' ' 3' ' ' PRO . 3.9 Cg_exo -62.65 130.98 31.53 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.967 1.778 . . . . 0.0 112.458 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 5' ' ' THR . 3.3 t -126.27 86.88 57.27 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 109.072 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.454 ' HA ' ' CE2' ' A' ' 19' ' ' PHE . 3.0 Cg_exo -55.67 151.58 38.55 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.585 1.523 . . . . 0.0 112.138 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.551 ' CD ' ' OD1' ' A' ' 15' ' ' ASP . 2.8 Cg_endo -58.89 -69.92 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.589 2.192 . . . . 0.0 111.984 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 172.89 175.7 40.94 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.14 -33.64 75.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.382 -1.069 . . . . 0.0 110.082 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 -58.66 -32.62 69.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.21 -0.931 . . . . 0.0 109.736 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.88 149.49 92.63 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.245 -0.909 . . . . 0.0 109.851 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -50.0 146.55 16.76 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.741 2.294 . . . . 0.0 111.99 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.11 -18.3 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.325 -0.859 . . . . 0.0 110.205 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.79 -36.21 82.39 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 120.974 -1.078 . . . . 0.0 109.16 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.551 ' OD1' ' CD ' ' A' ' 7' ' ' PRO . 13.3 t70 -61.94 -41.54 98.09 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.573 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 45.0 mt -65.58 -36.63 84.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.254 -0.904 . . . . 0.0 110.001 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.7 mt -59.43 -49.62 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.072 -1.018 . . . . 0.0 110.146 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.508 ' O ' ' ND2' ' A' ' 21' ' ' ASN . 22.9 mtp180 -62.58 -42.03 99.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.651 -1.281 . . . . 0.0 109.471 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.454 ' CE2' ' HA ' ' A' ' 6' ' ' PRO . 6.9 m-85 -61.18 -34.64 75.38 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -58.01 -38.15 75.62 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -59.35 -45.96 89.96 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.028 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -61.79 -37.49 84.56 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.428 HD23 ' HD2' ' A' ' 26' ' ' TYR . 5.9 mt -62.73 -36.74 83.98 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.498 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 63.5 tt0 -58.93 -47.67 84.22 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.354 -0.842 . . . . 0.0 108.926 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.925 ' O ' HG22 ' A' ' 29' ' ' VAL . 61.1 tt0 -63.7 -41.35 98.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.169 -0.957 . . . . 0.0 108.92 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.618 ' CD1' ' C ' ' A' ' 26' ' ' TYR . 0.3 OUTLIER -66.03 -51.68 56.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.609 -0.682 . . . . 0.0 110.071 -179.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.537 ' O ' HG23 ' A' ' 30' ' ' VAL . 89.4 mt -74.08 -38.47 63.89 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.918 -1.114 . . . . 0.0 110.325 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 24' ' ' GLN . 25.3 t30 -62.83 -42.58 99.79 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.991 -1.068 . . . . 0.0 110.56 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.925 HG22 ' O ' ' A' ' 25' ' ' GLN . 31.3 m -76.85 -31.09 18.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 120.92 -1.113 . . . . 0.0 108.778 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 27' ' ' LEU . 76.9 t . . . . . 0 C--N 1.304 -1.394 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.696 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo . . . . . 0 N--CA 1.483 0.897 0 N-CA-C 110.013 -0.803 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.751 ' O ' ' CG ' ' A' ' 2' ' ' PHE . 8.6 p90 -127.16 87.15 57.17 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.104 -0.997 . . . . 0.0 109.478 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.523 ' N ' ' CD ' ' A' ' 4' ' ' PRO . 4.1 Cg_exo -61.35 -43.65 27.27 Favored 'Trans proline' 0 C--N 1.299 -2.056 0 C-N-CA 122.619 2.212 . . . . 0.0 114.079 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' A' ' 3' ' ' PRO . 3.2 Cg_exo -64.41 140.75 71.3 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 C-N-CA 122.324 2.016 . . . . 0.0 112.514 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.64 144.21 30.95 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.298 -0.876 . . . . 0.0 108.919 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 2.5 Cg_endo -56.0 151.07 43.74 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.104 1.869 . . . . 0.0 111.986 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 2.4 Cg_endo -79.03 168.02 21.17 Favored 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 122.199 1.933 . . . . 0.0 111.885 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.37 155.89 53.18 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -60.88 -38.93 87.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.885 -1.362 . . . . 0.0 109.346 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -71.73 -24.75 61.84 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.466 -0.772 . . . . 0.0 109.993 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.76 142.42 16.43 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.131 -0.981 . . . . 0.0 110.022 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -52.71 148.34 28.43 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.605 2.204 . . . . 0.0 112.073 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.02 -23.17 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.296 -0.877 . . . . 0.0 109.734 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.67 -33.5 75.76 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 120.954 -1.092 . . . . 0.0 108.435 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -61.3 -40.34 93.8 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.468 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.6 mp -62.19 -41.3 98.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.131 -0.981 . . . . 0.0 108.735 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.2 mt -58.97 -44.25 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 119.427 -0.909 . . . . 0.0 108.684 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.476 ' HG3' ' ND2' ' A' ' 21' ' ' ASN . 18.9 ttm180 -61.69 -38.62 88.48 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.391 -0.818 . . . . 0.0 109.446 179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -55.74 -46.36 77.84 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.261 -0.899 . . . . 0.0 108.889 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -61.68 -39.19 90.55 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.569 ' ND2' ' OD1' ' A' ' 22' ' ' ASP . 0.0 OUTLIER -60.0 -44.46 94.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.408 -0.808 . . . . 0.0 109.344 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.569 ' OD1' ' ND2' ' A' ' 21' ' ' ASN . 89.9 m-20 -59.51 -40.74 88.09 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.285 -0.885 . . . . 0.0 109.718 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 38.0 tp -60.07 -41.07 91.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.023 -1.048 . . . . 0.0 108.959 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.446 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 46.1 tt0 -60.81 -38.46 85.46 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.84 ' O ' HG22 ' A' ' 29' ' ' VAL . 61.8 tp60 -60.58 -40.21 90.91 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.393 -0.817 . . . . 0.0 108.953 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.442 ' CD1' ' C ' ' A' ' 26' ' ' TYR . 25.2 t80 -69.02 -52.54 27.65 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.348 -0.845 . . . . 0.0 110.079 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.48 ' O ' ' CG2' ' A' ' 30' ' ' VAL . 78.2 mt -70.16 -37.53 75.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.358 -0.839 . . . . 0.0 110.237 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 24' ' ' GLN . 29.1 t30 -68.29 -41.29 81.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.117 -0.989 . . . . 0.0 110.83 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.84 HG22 ' O ' ' A' ' 25' ' ' GLN . 17.3 m -78.99 -35.19 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 120.974 -1.079 . . . . 0.0 109.49 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.48 ' CG2' ' O ' ' A' ' 27' ' ' LEU . 25.1 t . . . . . 0 C--N 1.302 -1.472 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.607 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo . . . . . 0 N--CA 1.481 0.764 0 N-CA-C 109.612 -0.957 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.712 ' CE2' ' O ' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -136.72 128.77 17.08 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.182 -0.949 . . . . 0.0 109.377 179.737 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.508 ' N ' ' HD2' ' A' ' 4' ' ' PRO . 3.5 Cg_exo -57.55 -43.52 50.2 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 122.405 2.07 . . . . 0.0 114.018 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.712 ' O ' ' CE2' ' A' ' 2' ' ' PHE . 3.5 Cg_exo -59.7 140.89 95.68 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.693 1.595 . . . . 0.0 112.367 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.34 160.98 39.39 Favored Pre-proline 0 N--CA 1.491 1.61 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -55.55 150.9 40.79 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 C-N-CA 121.628 1.552 . . . . 0.0 111.799 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -79.29 -67.05 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 121.921 1.747 . . . . 0.0 112.296 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 145.26 148.12 4.76 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -57.88 -44.55 86.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.036 -1.273 . . . . 0.0 109.979 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -71.9 -29.14 64.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.242 -0.912 . . . . 0.0 109.558 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -46.93 124.83 8.26 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.278 -0.889 . . . . 0.0 109.992 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -61.86 155.89 52.02 Favored 'Trans proline' 0 N--CA 1.489 1.258 0 C-N-CA 121.971 1.781 . . . . 0.0 111.688 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.9 p -56.01 -19.26 6.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.223 -0.923 . . . . 0.0 109.881 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -64.89 -41.93 95.2 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 120.987 -1.07 . . . . 0.0 108.545 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -67.03 -40.97 87.34 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.719 -0.792 . . . . 0.0 109.095 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.4 -38.53 87.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.391 -0.818 . . . . 0.0 109.091 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 54.2 mt -57.65 -53.83 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.423 -0.798 . . . . 0.0 110.209 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.73 ' HE ' ' C ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -55.59 -39.55 70.87 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.097 -1.002 . . . . 0.0 108.52 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.595 ' N ' ' HE ' ' A' ' 18' ' ' ARG . 13.3 t80 -62.42 -42.96 99.84 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.443 -0.786 . . . . 0.0 109.191 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -58.4 -43.49 88.58 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.481 -0.762 . . . . 0.0 109.541 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.766 ' OD1' ' N ' ' A' ' 22' ' ' ASP . 28.1 p30 -69.06 -32.87 72.65 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.142 -0.974 . . . . 0.0 109.967 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.766 ' N ' ' OD1' ' A' ' 21' ' ' ASN . 88.0 m-20 -63.55 -44.35 94.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.156 -0.965 . . . . 0.0 109.618 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.7 tp -65.87 -40.21 91.41 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.319 -0.863 . . . . 0.0 109.493 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.445 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 36.0 tt0 -60.39 -47.61 85.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.276 -0.89 . . . . 0.0 109.21 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.787 ' O ' HG22 ' A' ' 29' ' ' VAL . 97.3 mt-30 -66.01 -33.47 75.88 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.21 -0.931 . . . . 0.0 108.844 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.566 ' C ' ' CD1' ' A' ' 26' ' ' TYR . 0.8 OUTLIER -64.37 -55.75 19.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.465 -0.772 . . . . 0.0 110.363 -179.588 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.561 ' O ' HG23 ' A' ' 30' ' ' VAL . 96.2 mt -76.93 -38.81 52.67 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.093 -1.004 . . . . 0.0 110.381 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.445 ' CB ' ' O ' ' A' ' 24' ' ' GLN . 17.9 t30 -61.72 -43.12 99.46 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.152 -0.968 . . . . 0.0 110.74 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 25' ' ' GLN . 15.7 m -71.76 -30.8 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 120.921 -1.112 . . . . 0.0 108.82 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.575 ' O ' ' O ' ' A' ' 29' ' ' VAL . 71.4 t . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.586 179.344 . . . . . . . . 1 1 . 1 stop_ save_